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Sumário 
 
O objetivo desta dissertação foi descobrir mecanismos de sobrevivência das células B durante 
o processo de resposta a antigénios. Este trabalho revelou que expressão da cadeia pesada da 
imunoglobulina é suficiente para assegurar a sobrevivência de linfócitos B na ausência de 
cadeias leves. Estes resultados sugerem que a cadeia pesada origina sinais de sobrevivência de 
forma constitutiva e independente de ligação a ligandos específicos para o receptor composto 
de cadeias de imunoglobulina pesadas e leves. Na segunda parte de tese, procurámos 
determinar mecanismos de sobrevivência de células B sujeitas a quebras do ADN durante os 
processos de mudança de isótipo e a hipermutação somática da imunoglobulina. Os nossos 
resultados revelaram que a enzima “activation induced cytidine deaminase” (AID), que inicia 
os processos de mudança de isótipo e de introdução de mutações somáticas nos genes 
codificadores das cadeias de anticorpos, (Muramatsu et al., 2000), é também responsável pela 
reparação do ADN, permitindo assim às células B evitar a apoptose induzida por danos 
persistentes no ADN. Observámos, (Wu et al., 2005), que a AID recruta a subunidade 
catalítica da ADN proteína quinase (DNA-PKcs) sugerindo que a AID coordena a reparação 
de quebras no ADN, contribuindo desta forma para a sobrevivência das células B. 
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Sumário alargado 
 
A imunidade adaptativa é assim designada por não ser antecipatória, ao contrário da 
imunidade inata, desenvolvendo-se sempre em resposta a estímulos sejam estes infecciosos, 
tóxicos ou outros. Se, por um lado, a natureza não antecipatória da imunidade adaptativa 
limita o desenvolvimento rápido de respostas protetoras aquando do primeiro encontro com 
um novo estímulo imunológico, por outro, tem a capacidade de formar um histórico ou 
“imprint” da resposta a cada estímulo. Esta é a sua principal vantagem, na medida em que 
assegura uma proteção mais rápida e eficaz aquando de um segundo encontro com um mesmo 
estímulo. Este histórico e a sua manifestação são conhecidos por memória imunológica.  
 
O advento da memória imunológica requer um reconhecimento específico do estímulo e a 
sobrevivência das células que medeiam a resposta a este primeiro encontro, de forma a 
permitir uma subsequente ativação e resposta efetora com maior rapidez e intensidade que a 
resposta inicial. 
 
A memória imunológica foi historicamente a primeira característica da imunidade adaptativa a 
ser reconhecida (Panum, 1847). Apesar de largamente manipulada na prevenção de doenças, 
os mecanismos necessários para o desenvolvimento e manutenção da memória imunológica 
não são ainda inteiramente conhecidos. No início do século XX Von Behring e Kitasato 
(Silverstein, 1999) descobriram antitoxinas, demonstrando que algumas propriedades da 
imunidade adaptativa podiam ser transferidas pelo soro. Ehrlich (Ehrlich and Morgenroth, 
1957) chamou aos efetores humorais anticorpos, e demonstrou que os estes criavam respostas 
imunes específicas. Landsteiner and Chase (Landsteiner and Chase, 1941) descobriram em 
1941 que a imunidade podia ser transferida por células. Assim em meados do século XX os 
efetores da imunidade adaptativa foram reconhecidos (células e anticorpos) assim como as 
suas propriedades fundamentais (imunidade adquirida, especificidade e memória). 
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É geralmente aceite que o primeiro encontro com o antigénio estimula as células B (as células 
que produzem anticorpos) não só a diferenciarem-se em plasmócitos mas também a 
originarem populações de células de memória (Gray, 1988) e de plasmócitos de maior 
longevidade (Manz et al., 2002). As células B de memória diferem de células B "naives" na 
sua longevidade, no tipo de imunoglobulina (normalmente de isótopos diferentes) e na 
presença de mutações acumuladas nos exões variáveis (V) das cadeias pesadas e leves das 
imunoglobulinas, evidência de hipermutação somática (Meffre et al., 2001). A rapidez das 
respostas de memória deve-se não só a um maior número de células específicas para antigénio 
que o número de células "naives" com essa mesma especificidade (Ahmed and Gray, 1996), 
como também à maior afinidade do receptor B para o antigénio capaz de ser ativado por doses 
diminutas de antigénio, bem como devido a propriedades facilitadoras de ativação distintas de 
certas classes de IgG (Liu et al., 2010; Martin and Goodnow, 2002). As células B de memória 
que persistem, ou continuamente geradas por persistente presença de antigénio, são 
responsáveis pelas respostas aceleradas de eficácia aumentada que caracteriza as respostas de 
anticorpos secundárias. Uma vez que os plasmócitos não expressam Ig de superfície, e não se 
dividem, não contribuem para as propriedades das respostas secundárias, mas apenas para a 
persistência de anticorpos específicos que secretam enquanto vivem. 
 
Desconhecem-se os mecanismos pelos quais as células B adquirem e mantêm longevidade. 
Lam et al. (Lam et al., 1997) mostraram que deleção do exão V da cadeia pesada, abolindo a 
expressão da cadeia pesada, causa a apoptose de células B maduras. Kraus, M. et al. (Kraus et 
al., 2004) demonstraram que inibição de sinal do receptor B em células B maduras conduz à 
morte rápida destas células (em dias), sugerindo que os sinais do receptor das células B são 
necessários para a sobrevivência destas células. Não ficou porém explicado se o receptor das 
células B promove a sobrevivência de células B através da ligação a um ligando genérico ou 
através de um sinal constitutivo independente de um ligando. 
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O objetivo desta dissertação foi assim descobrir os elementos que contribuem para a 
sobrevivência das células B durante o processo de ativação. Em primeiro lugar, questionamos 
se a sobrevivência das células B dependia da presença de um receptor B intacto. Apesar do 
trabalho de Kraus et al. (Kraus et al., 2004) evidenciar que a sobrevivência das células B 
depende de um sinal a partir do receptor B, observamos na natureza em diversas 
circunstâncias a existência de células B sem este receptor. Por exemplo, células B sem 
receptor que expressam um receptor do vírus Epstein Barr conseguem sobreviver (Casola et 
al., 2004), ou no caso dos camelos (Muyldermans and Lauwereys, 1999) e alguns tubarões 
(Greenberg et al., 1995a) em que as células B sobrevivem sem um receptor B convencional e 
secretam anticorpos incompletos apenas com a cadeia pesada da imunoglobulina. 
 
No sentido de determinar se a cadeia pesada da imunoglobulina permite, por si só, a 
sobrevivência de células B, utilizamos um modelo em que a expressão da cadeia leve da 
imunoglobulina (IgL) podia ser transientemente reprimida: o “IgL repressible mouse”. Este 
modelo permitiu estudar como a repressão da cadeia leve em células B que mantinham a 
expressão da cadeia pesada afetava a sua longevidade. As nossas observações indicam que 
células B que expressam apenas a cadeia pesada da imunoglobulina sobrevivem e persistem. 
Concluímos assim que a sobrevivência das células B não requer a expressão de um receptor B 
completo. Interessava agora elucidar o mecanismo responsável por esta observação. Uma vez 
que os nossos resultados demonstravam que as células B sem IgL expressam na sua superfície 
uma cadeia pesada integrada num receptor incompleto, propusemo-nos investigar a hipótese 
de que este receptor ser capaz de sinalizar. As nossas observações revelaram que é 
efetivamente o caso, o que nos levou a concluir que o sinal transduzido pela cadeia pesada 
pode ser o único mecanismo necessário para a sobrevivência destas células. Por outro lado, a 
acumulação de cadeias pesadas no retículo endoplasmático resultante da ausência de cadeias 
leves, também pode contribuir para a sua sobrevivência. De acordo com esta possibilidade, 
observámos que as células B IgL negativas exibiam ativação de uma resposta de stress à 
acumulação de proteínas no retículo endoplasmático: “unfolded protein response”. Esta 
resposta de stress é responsável pela ativação de diversos fatores de sobrevivência em células 
B. Concluímos assim que as cadeias pesadas não emparelhadas com cadeias leves podem 
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promover a sobrevivência das células B ou através de sinais provenientes de complexos 
membranares incompletos ou através da ativação da “unfolded protein response” (Geraldes et 
al., 2007) 
 
O surgimento de células B de grande longevidade após ativação é ainda mais intrigante 
considerando que a maioria é sujeita a numerosas quebras da cadeia dupla de ADN, durante a 
ativação e multiplicação clonal que acompanham a recombinação para mudança de isótipo e a 
hipermutação somática. Normalmente, as células respondem a quebras na cadeia dupla de 
ADN parando o ciclo celular de forma a terem tempo para reparar os danos (Nyberg et al., 
2002) e respondem a danos persistentes induzindo apoptose, presumivelmente para evitar 
recombinação ilegítima (Nyberg et al., 2002). 
 
O processo através do qual as células B de memória, que exibem isótopos alterados e 
mutações nos exões variáveis da imunoglobulina, sobrevivem a múltiplas quebras no ADN 
não e ainda claro. Procurámos assim determinar se a enzima “activation induced cytidine 
deaminase” (AID), enzima que inicia a mudança de isótipo e a hipermutação somática da 
imunoglobulina (Muramatsu et al., 2000), era também responsável pela reparação do ADN, 
permitindo assim às células B evitar a apoptose induzida por danos persistentes no ADN. 
Observámos (Wu et al., 2005) que a AID recruta a subunidade catalítica da ADN proteína 
quinase (DNA-PKcs) sugerindo que a AID coordena a reparação de quebras no ADN, 
contribuindo desta forma para a sobrevivência das células B. 
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Abstract 
 
Our overall objective was to find mechanisms of B cell survival during antigen response. In 
the first part of this work, we revealed that immunoglobulin heavy chain expression is 
sufficient for B cell survival in the absence of light chain. We showed that the heavy chain 
alone can reach the cell surface as a part of an incomplete signal competent B cell receptor. 
These results are consistent with the hypothesis that the heavy chain alone can produce 
survival signals constitutively and independently of specific antigen recognition. We also 
showed an alternative hypothesis for B cell survival through the activation of an unfolded 
protein response, which is caused by heavy chain accumulation in the endoplasmatic reticulum 
in the absence of light chain. 
In the second part of this work we looked for B cell survival mechanisms during activation 
and terminal differentiation. Specifically, how B cells survive DNA double strand breaks 
caused by class switch and somatic hypermutation of the immunoglobulin gene. Our results 
showed a novel role for the activation induced cytidine deaminase (AID), an enzyme 
responsible for class switch and introduction of somatic mutations in the immunoglobulin 
genes (Muramatsu et al., 2000). We showed that AID is involved in DNA repair by recruiting 
the catalytic subunit of the DNA protein kinase (DNA-PKcs) (Wu et al., 2005). These results 
suggest that AID coordinates double strand break repair and contributes to B cell survival 
during terminal differentiation 
 
Keywords 
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Immunoglobulin Heavy Chain (HC) 
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Unfolded protein response (UPR) 
Activation induced cytidine deaminase (AID) 
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Introduction 
 
Adaptive immune responses of vertebrates have distinct properties from those of innate 
immunity universally exhibited by all multicellular organisms. Adaptive immunity is acquired, 
while innate immunity is inherited. Adaptive immunity evolves and forms an imprint of prior 
encounters, referred to as immunological memory, while innate immunity responses are fixed 
and repetitive, targeting highly conserved structures of known pathogens. Adaptive immunity 
mounts specific responses to an almost infinite number of varying structures displayed by 
infectious agents, toxins and other foreign molecules, while innate immunity responses are 
non-specific. The acquired specificity of adaptive immune responses depends on the 
availability of an enormous diversity of receptor molecules (B cell receptors and T cell 
receptors) that result from random assembly of precursor gene segments.  
 
Immunological memory was, historically, the first feature of the adaptive immunity to be 
recognized (Panum, 1847). Although widely manipulated for the prevention of disease, the 
specific mechanisms necessary to develop and maintain immunological memory are still not 
completely understood today. One essential condition for the generation of immunological 
memory is that lymphocytes survive activation and persist quiescently even when antigen is 
no longer available for long periods of time. Upon re-exposure, the persisting lymphocytes 
must respond with enhanced kinetics and mount more effective responses in part owing to 
enhanced antigen binding capabilities compared to their naïve progenitors. This thesis 
concerns studies on the molecular mechanisms that contribute to the survival of B cells 
following activation.  
 
In the early 20
th
 century, Von Behring and Kitasato (Silverstein, 1999) discovered anti-toxins 
demonstrating that some properties of adaptive immunity could be transferred by sera. Ehrlich 
(Ehrlich and Morgenroth, 1957) called the humoral effectors, antibodies, and demonstrated 
that antibodies mount specific immune responses. Landsteiner and Chase (Landsteiner and 
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Chase, 1941) discovered in 1941 that immunity could be transferred by cells. Thus by mid-
century the effectors of adaptive immunity antibodies and cells had been established as well as 
the fundamental properties of adaptive immunity: acquired, specificity and memory. 
 
How B cells acquire and maintain long life is not known. Lam et al. (Lam et al., 1997), 
showed that conditional ablation of the VH exon in mature B cells, abolishing heavy chain 
expression led to the apoptosis of B cells. Kraus, M. et al. (Kraus et al., 2004) showed loss of 
mature B cells upon induced mutation of a signalling module of the BCR, not precluding BCR 
surface expression. The research suggested BCR signalling to be an absolute requirement for 
B cell survival. 
 
Consistent with the idea that BCR signalling is needed for B cell survival, Kraus et al. (Kraus 
et al., 2004) showed that ablation of Ig signalling causes mature B cell death. However, B cells 
that lack a BCR exist under certain circumstances. For example, BCR-less B cells that express 
an Epstein Barr Virus receptor survive (Casola et al., 2004), and in camels (Muyldermans and 
Lauwereys, 1999) nurse shark (Greenberg et al., 1995) wobbegong shark and in ratfish (Rast 
et al., 1998) B cells lacking a conventional BCR live and secrete heavy-chain only antibodies. 
These studies suggested the possibility that at least under certain circumstances, expression of 
unpaired Ig heavy chain may sustain B cell survival. 
 
The overall goal of this thesis was to discover elements contributing to the survival of B cells. 
We first examined the requirement of an intact BCR for the survival of B cells. To determine 
whether unpaired heavy-chain sustained B cell survival, we studied a mouse model engineered 
with a repressible Ig light chain gene (the Ig-L repressible mouse). We examined how 
repression of light chain in B cells that maintained heavy chain expression impacted on B cell 
survival. We found that survival of mature B cells did not require the expression of a complete 
BCR. B cells expressing Ig heavy chain alone were long-lived. Since Light-chain negative B 
cells expressed a signalling competent heavy chain on the surface of cells, we proposed that Ig 
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heavy chain signalling may be one mechanism contributing to B cell survival. While in most 
cells persisting unfolded protein responses target cells for destruction by phagocytosis, in B 
cells persisting unfolded protein responses are associated with terminal differentiation into 
plasma cells. Consistent with this concept, we found that repression of Ig Light chain 
expression enhanced differentiation of B cells into Ig heavy chain secreting cells. We 
concluded that unpaired heavy chains promote survival either by signalling from membrane 
complexes or by stimulating the unfolded protein response and differentiation of B cells. 
(Geraldes et al., 2007). 
 
The generation of long-lived B cells is all the more intriguing considering that most 
differentiate after undergoing numerous DNA double strand breaks during class switch 
recombination and somatic hypermutation. Ordinarily, cells respond to DNA double-strand 
breaks by undergoing cell cycle arrest to allow time for repair (Nyberg et al., 2002) and 
respond to persistent DNA damage by inducing apoptosis, presumably as a protection against 
illegitimate recombination (Pfeiffer et al., 2000). How memory B cells that often express 
switched immunoglobulin isotypes and have mutations in the variable exons of the Ig heavy 
and light chains, survive multiple rounds of DNA breaks is not understood. In my thesis I 
examined whether activation-induced cytidine deaminase (AID) the enzyme that initiates 
somatic hypermutation (SHM) and class switch recombination (CSR) of Ig genes (Muramatsu 
et al., 2000) orchestrated DNA repair thus rescuing B cells from DNA damage induced 
apoptosis. Our studies (Wu et al., 2005) demonstrated that AID recruits DNA protein kinase, 
catalytic sub unit (DNA-PKcs) suggesting that AID effectively coordinates repair with DNA 
breaks and in this way avoid apoptosis. 
 
B cell development 
 
B cell development, as generally viewed today, comprises two major phases marked by the 
properties of immunoglobulin (Ig) genes. In the first phase Ig heavy (H) and light (L) chain 
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genes are assembled from gene segments by V(D)J recombination to encode Ig heavy (H) and 
light (L) chains that constitute the B cell receptor (BCR). In the second, foreign antigen drives 
expansion of the B cells bearing a cognate BCR and they differentiate into either antibody-
secreting plasma cells or into memory B cells. 
 
Contrary to all other proteins with the exception of the T cell receptor, IgH and IgL chain 
genes are not encoded in the germline. In order to assemble a competent IgH or IgL gene B 
cells undergo DNA somatic recombination (called V(D)J recombination) which permits the 
random union of several V, D and J gene segments picked more or less randomly from a pool. 
The IgH chain V region is assembled first by joining a variable (VH), a joining (JH) and 
diversity (DH) segment. The joining of DH to a JH segment occurs first, followed by the 
rearrangement of a VH segment with to a DJH segment. Then the IgL chain rearranges by 
joining the variable (VL) and joining (JL) segments. V(D)J recombination H and L chain 
pairing potentially generates a BCR repertoire  diversity of 10
11
 different receptors (Glanville 
et al., 2009; Jackson et al., 2013). V(D)J recombination results in the assembly of IgH and IgL 
variable exons that are brought to the proximity of the gene fragments encoding the Ig 
constant regions and to enhancer elements to drive effective transcription. 
 
V(D)J recombination is initiated by a DNA cleavage step that is mediated by the 
recombination-activity genes 1 and 2 (RAG1 and RAG2) followed by DNA joining step 
mediated by non-homologous end joining pathway of DNA double strand repair (Helmink and 
Sleckman, 2012). The cleavage of DNA occurs adjacent to recombination sequences 
composed of heptamers and nonamers flanking a 12 or 23 non-conserved nucleotide spacer 
during the G1 stage of the cell cycle. DNA cleavage results in a pair of hairpin sealed coding 
ends and in a pair of blunt phosphorylated signal ends. The coding and signal ends are 
processed differently but remain in a complex until they can be joined. Joining of coding ends 
requires opening of the hairpins at a random position creating ends of different lengths which 
are filled in by addition of palindromic nucleotides (P). In addition the ends resulting from the 
opening of the hairpins are trimmed by exonucleases followed by addition of non-templated 
 29 
nucleotides (N) (Helmink and Sleckman, 2012). Since processing of the coding ends includes 
variable addition and/or deletion of nucleotides the length of the junction will vary and only 
one third of the junctions will encode an in frame sequence (Helmink and Sleckman, 2012). 
Apart from generating a functional antigen receptor chain, coding joint formation also assures 
chromosomal integrity, necessary to preserve genomic stability. In contrast to coding joint 
formation, signal joints are joined precisely and in most cases form an extra-chromosomal 
circle that is lost upon cell division as it lacks replication ability. In the case of the Igκ locus, 
however, both coding and signal joints contribute to chromosomal integrity since VJ 
recombination causes inversion of the intervening sequences rather than deletion (Helmink 
and Sleckman, 2012). 
 
The development of new B lymphocytes from their uncommitted precursors takes place in the 
bone marrow of adult mammals and is defined by the stepwise assembly of a competent BCR. 
Heavy (H)-chain genes are formed at the pro-B cell stage. Productive rearrangement of the 
VH segments leads to the expression of an IgH chain which is expressed on the surface in 
combination with a surrogate light chain to form the pre-B cell receptor. Only a minority 
(15%) of the proB cells transition successfully to the next stage. That is because only one out 
of every three heavy chain rearrangements places the VH gene segment in frame with the JH 
sequence, and because only one half of all the productive heavy chains pair with the surrogate 
light chain or mature light chains. Lack of heavy chain or pre-BCR expression causes arrest of 
B cells at the pro-B cell stage (Chen et al., 1993). 
 
V(D)J rearrangement depends on VH gene accessibility and on the availability of 
Recombination activation genes 1 and 2 (RAG1 and RAG2). It is generally thought that 
transcription of germline VH sequences and chromatin remodeling render the VH and D 
segments accessible to the recombinase. This process requires the cytokine IL-7, and the 
transcription factors Pax5 and YY1. Transcription of the RAG genes depends on the function 
of Forkhead (FOX)p1 transcription factors(Kurosaki et al., 2010b). 
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The pre B cell receptor controls the clonal expansion of pre B cells. Pre-B cells undergo 
several divisions before rearranging the light (L)-chain genes. This rearrangement usually 
occurs first at the κ locus and then at the λ locus. Several attempts can be therefore made to 
rearrange a functional IgL chain and thus most pre-B cells survive to the immature B cell 
stage. Lack of L chain causes arrest at the pre-B cell stage of development (Spanopoulou et 
al., 1994; Young et al., 1994). Once a productive IgL chain is assembled and a complete BCR 
expressed on the surface, the pre-B cell becomes an immature B cell, which travels from the 
bone marrow through blood and lymph to the periphery, e.g., spleen, and lymph nodes where 
it further matures or dies.  
 
We have discussed before that gene rearrangement is not an exact process so that it can give 
rise to a diverse repertoire of receptors. Thus, this process also gives rise to many non-
productive rearrangements that need to be selected against in order to preserve the productive 
ones. Also, because in a diploid genome there are two alleles one in each immunoglobulin 
locus, a productive rearrangement must stop the process immediately and signal for the next 
developmental stage (allelic exclusion). 
 
IgH allelic exclusion is the process by which successful rearrangement of one IgH allele 
inhibits further rearrangement of the other allele. IgH allelic exclusion is thought to occur after 
the transient surface expression of the newly rearranged functional IgH as part of the pre-B 
cell receptor (pre-BCR). The pre-BCR contains a functional IgH coupled with a surrogate light 
chain consisting of VpreB and λ5 (Keyna et al., 1995) (Kline et al., 1998) (ten Boekel et al., 
1997). Non-productive IgH chains are unable to pair with surrogate light chains and are 
therefore retained in the endoplasmatic reticulum. The signals produced by the pre-BCR 
induce proliferation of the pre-B cell with a productive IgH rearrangement and provide a stop 
sign for further rearrangement (Hess et al., 2001) (Rolink et al., 2000). Although much 
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remains to be elucidated the mechanism requires Syk and Zap70 and PLCγ2(Kurosaki et al., 
2010b).  
 
Though a subject of controversy, pre-BCR-mediated proliferation of pre-B cells, in contrast to 
BCR-mediated proliferation of mature B cells, can occur independently of foreign antigens 
(Hess et al., 2001) (Rolink et al., 2000). Receptor self-aggregation is thought to be necessary 
for pre-BCR signaling. Thus Ohnishi and Melchers (Ohnishi and Melchers, 2003) proposed 
that the unique, non-Ig N-terminal tail of l5 and the C-terminus of V-PreB mediate homotypic 
interactions leading to pre-BCR clustering. The pre-BCR signaling renders the pre B cell 
independent of IL-7 for expansion and involves activation of Src family and Syk family 
kinases. The downstream events of pre-BCR signaling are yet to be clearly delineated 
(Kurosaki et al., 2010a). Pre-BCR mediated proliferation signals differ from those of mediated 
by the BCR of mature B cells in that the selection criteria is for a functional IgH chain 
irrespective of its specificity (Keyna et al., 1995) (Kline et al., 1998) (ten Boekel et al., 1997). 
Thus, a broader mechanism of selection is implied. About 12-15% of the pre-B cells arrange a 
functional IgH chain (ten Boekel et al., 1997). Interestingly, though SLC deficient pre-B cells 
expressing a functional IgH chain fail to proliferate efficiently, they can survive and 
differentiate (Hess et al., 2001) (Rolink et al., 2000). 
 
After pre-B cell clonal expansion, pre-B cells arrest in G1 and become small pre-B cells. Since 
Pre-BCR signaling terminates the transcription of the genes encoding λ5 and V-preB, it is 
possible that the end of clonal expansion is causes by the depletion of complete pre-BCR 
receptors (Kurosaki et al., 2010b). Following cessation of proliferation, IgL loci become 
accessible, the rearrangement of the IgL chain follows and a complete functional IgM 
molecule is formed and expressed on the surface together with Igα and Igβ to form a 
functional BCR (Geier and Schlissel, 2006).  
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B cell selection and clonal deletion 
 
The BCR determines whether a B cell lives or dies or whether it progresses to mount a 
productive immune response. How the BCR determines B cell survival is incompletely 
understood. A subject of controversy has been whether the BCR delivers a “survival signal” in 
the absence of a ligand (constitutive activation), or whether is continuously activated by 
endogenous ligands. The BCR also determines whether B cells become unresponsive (anergy), 
die (deletional tolerance) or whether they mount productive immunity to stimuli and 
differentiate into memory B cells or plasma cells. Thus, immature B cells that bind self-
antigens are removed from the functional pool by clonal deletion (i.e., physical destruction) 
(Nemazee and Buerki, 1989) (Nemazee and Buerki, 1989) or undergo anergy (i.e., functional 
shutdown) (Berg et al., 1988), unless its L and/or H-chain genes are “edited” so that they no 
longer bind self-antigens (Nemazee, 2000).   
 
In contrast, mature B cells that come in contact with foreign cognate antigen differentiate into 
antibody producing plasma cells or into-long-lived memory B cells. How B cells decipher 
whether a BCR signal should be interpreted, as a survival signal as opposed to a death signal, 
is not understood.   
 
Survival of B cells following stimulation is determined by competition for antigen, T cell help 
and presumably by the availability of favorable niches that provide ideal growth conditions. 
Upon activation, B cells undergo frequent mutagenesis of the Ig variable heavy and light chain 
exons (Ig somatic hypermutation) (Wabl et al., 1985). This process changes the binding 
specificity of the BCR, may enhance affinity (the binding strength of each antigen binding 
site) of the BCR for antigen and creates intra-clonal diversity (Neuberger and Milstein, 1995).  
In addition, B cells undergo recombination and deletion of gene segments within the heavy 
chain constant region a process that mediates isotype class switch (von Schwedler et al., 
1990). Somatic hypermutation introduces random point mutations in the rearranged V region 
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of Ig genes, allowing the generation of B cells with different antigen affinities within a clone 
(Cascalho et al., 1999). The diversity of B cells created by somatic hypermutation provides the 
small fraction of B cells with higher affinity for antigen with a survival advantage. The 
survival advantage may be contributed by enhancing antigen capture when antigen 
concentration is limiting, which in turn, may increase antigen presentation to cognate T cells 
enhancing T cell help (Schwickert et al., 2011) (Schwickert et al., 2011). In addition, B cells 
with receptors with higher affinity for antigen suppress the clonal expansion of low affinity B 
cells (Shih et al., 2002). Class switch recombination, exhanges the Ig heavy-chain Cμ region 
with one of the other heavy chain constant regions, resulting in the generation of antibodies of 
different isotypes and effector functions.   
 
Somatic Hypermutation and class switch recombination are initiated by the activation induced 
cytidine deaminase (AID) encoded by the AICDA gene. AID is absolutely necessary to induce 
somatic hypermutation and/or isotype class switch because mice or human subjects that lack 
AID do not produced mutated antibodies, switched Ig isotypes and have deficient B cell 
memory (Muramatsu et al., 2000). Conversely transfection of the AID gene into fibroblasts is 
sufficient to induce mutation and switching events (Okazaki et al., 2002) indicating that AID 
works in cells other than B cells. 
 
The function of AID as a cytidine deaminase was first proposed on the basis of its homology 
with the apolipoprotein B mRNA-editing catalytic polypeptide 1 (Kim et al., 2002). Exactly 
how AID introduces point mutations or executes class switch recombination is not yet 
completely understood, but it is generally thought that cytidine deamination of DNA (or RNA) 
somehow generates double-strand breaks in Ig DNA (Durandy, 2003) (Papavasiliou and 
Schatz, 2000) (Petersen et al., 2001) (Rogosch et al., 2012) (Celeste et al., 2002). 
 
Ordinarily, cells respond to DNA double-strand breaks by undergoing cell cycle arrest to 
allow time for repair (Nyberg et al., 2002) and respond to persistent damage by inducing 
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apoptosis, likely as a protection against illegitimate recombination (Pfeiffer et al., 2000). 
However, B cells undergoing Ig class switch do not die, presumably because they efficiently 
repair DNA double-strand breaks. Although RAD54, RAD52, and RAD51 repair proteins are 
needed for AID-induced Ig gene conversion in chicken cell lines (Bezzubova et al., 1997) 
(Sale et al., 2001), whether AID directly recruits repair factors to the locales of cytidine 
deamination is not known.  In our work, we identified one possible mechanism contributing to 
AID-mediated recruitment of DNA repair factors (Wu et al., 2005).    
 
B cell memory  
 
Immunological memory is the ability of the immune system to respond more rapidly and 
effectively to pathogens that have been encountered previously. Enhanced responses might 
reflect the persistence of antigen-specific B cells bearing receptors that bind antigen with high 
affinity that remain quiescent following antigen clearance (memory B cells) and/or persistence 
of antigen specific plasma cells (long-lived plasma cells). 
 
It is generally accepted that a primary encounter with antigen stimulates specific B cells (the 
cells that produce antibodies) not only to differentiate into plasma cells, but also to give rise to 
populations of long-lived memory cells (Gray, 1988) and long lived plasma cells (Arce et al., 
2002). Memory B cells differ from naïve B cells in their lifespan and in the properties if the 
immunoglobulin (Ig) genes which are often class switched and have somatic mutations in the 
V exons (Meffre et al., 2001). Memory B cells contribute to the rapidity of the secondary 
responses as the number of memory antigen-specific B cells is greater than the number of 
antigen specific naïve B cells (Ahmed and Gray, 1996), and because responses from memory 
B cells occur faster than from naïve cells in part owing to an increased affinity B cell receptor 
for the antigen and to specific properties of the IgG BCR enhancing sensitivity and rapid 
activation (Martin and Goodnow, 2002) (Engels et al., 2009; Liu et al., 2010). Long-lived 
plasma cells are thought to maintain antigen-specific antibodies in the blood long after the 
 35 
antigen has cleared. Because plasma cells don’t express surface Ig they do not contribute to 
the properties of recall responses. Recent evidence suggests that plasma cells negatively 
regulate the follicular T helper program inhibiting further activation of antigen-specific B cells 
(Pelletier et al., 2010). 
The fundamental requirement for generation of B cell memory is that antigen specific B cells 
(memory B cells or long lived plasma cells) persist after stimulation. However the number of 
antigen-specific B cells persisting after stimulation probably decreases with time indicating 
that memory B cells form a heterogeneous population with diverse lifespans.   
 
In part, the uncertainties on the frequency of memory B cells and on how long they live are a 
consequence of a lack of consensus on a phenotype. Bona fide memory cells were defined as 
cells that carry somatic mutations in the V exons of the Ig genes (Dietrich et al., 1989) 
(Ahmed and Gray, 1996) (Bikah et al., 2000). This is because hypermutation of the V exons 
occurs upon B cell activation and clonal expansion, and because mutated B cells that bind 
antigen better have a survival advantage. However, since mutation per se is not required a 
better definition of memory B cell reflects their history and unique properties. Thus, 
Shlomchik and Weisel (Shlomchik and Weisel, 2012) recently defined memory B cell as the 
“member of a clone that has responded to antigen by proliferation, remaining in the animal in 
a resting state and at expanded frequency long after the initial stimulus”. 
 
In contrast to naïve B cells, memory B cells survival and activation is independent of B-
lymphocyte stimulator (BlyS or BAFF) (Good et al., 2009) (Scholz et al., 2008), and 
independent of T cell help (Hebeis et al., 2004) (Klinman and Doughty, 1973). Alternative 
markers have been sought but controversy remains on whether there is a common phenotype 
to all B cell memory cells (Balin and Cascalho, 2010) (McHeyzer-Williams et al., 2000). 
Some (Shlomchik and Weisel, 2012) defined subsets of memory B cells based on the 
expression of several surface markers including CD12/23, CD73, CD80 and PD-L2 (CD283) 
but their functional significance remains unclear.  
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A matter of debate is whether the maintenance of memory B cells requires continuous 
stimulation by antigen (Gray, 1988). Maruyama and colleagues (Maruyama et al., 2000) 
addressed this question with an elegant genetic switch. Based on their findings the authors 
concluded that maintenance of B cell memory occurs independently of antigen. However since 
the “new” Ig expressed by the memory B cells could in principle, still bind the immunizing 
antigen, the issue of whether B cell memory depends on antigen persistence or simply 
expression of Ig is not solved.  
 
A longstanding question in B cell memory is how cells in a clone decide to become either 
long-lived memory B cells or plasma cells. Three models have been proposed: (i) memory 
cells arise from a lineage different from the cells that constitute the primary response (Linton 
et al., 1989); (ii) memory cells arise from the same lineage of plasma cells and plasma cells 
are generated at low frequency as the clone grows (linear differentiation pathway) (Ahmed 
and Gray, 1996); (iii) as clones grow, the potential for memory cell development decreases 
(decreasing potential hypothesis) (Ahmed and Gray, 1996). While the jury is still out on which 
model best describes reality, Pape et al. (Pape et al., 2011) showed that while both antigen 
specific IgM and switched Ig memory B cells were generated, these cells differed in their 
responses to repeat stimulation and in their longevity. Thus the more numerous IgM+ cells 
were longer lived than the swig+ cells and responded to re-stimulation by forming germinal 
centers. In contrast, swig+ B cells provided early memory responses by quickly originating 
antibody-secreting cells but very few germinal centers. The results by Pape et al. suggested 
that the properties of memory B cells evolve with clonal expansion  and with time after 
antigen encounter and support the model first proposed by Ahmed and Gray (Ahmed and 
Gray, 1996) suggesting that the potential for memory B cell development decreases with 
clonal expansion.  
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In addition to memory B cells, long-lived plasma cells constitute the survivors of primary 
responses. Plasma cells are terminally differentiated B cells that lost Ig surface expression and 
for that reason are un-responsive to antigen (Manz et al., 1998). Thus, their sole function 
appears to be maintaining a low level of specific Ig in circulation to confer protection against 
pathogens or toxins while secondary responses get started (Slifka and Ahmed, 1998) (Manz et 
al., 1998) (McHeyzer-Williams and Ahmed, 1999). Long-lived plasma cells may last a life 
time (Crotty et al., 2003) (Slifka and Ahmed, 1998) and Ahuja et al. (Ahuja et al., 2008) 
showed that long lived plasma cells are maintained independently of memory B cells because 
extended depletion of memory B cells did not decrease the number of plasma cells in the bone 
marrow or spleen, or the steady state specific antibody levels. Instead, survival of long-lived 
plasma cells might depend on environmental factors in the bone marrow defining an optimal 
niche. Consistent with that idea Sze et al. (Moulin et al., 2000) determined that the spleen has 
the capacity to sustain between 20 and 100 plasma cells/mm
2
 beyond which cells are lost. 
When this number is exceeded, there is a loss of excess cells. Although the origin of long-
lived plasma cells has been linked to the germinal center, research from several laboratories 
suggests that these cells also arise in response to polysaccharide, T-independent antigens 
which typically do not stimulate germinal center formation (MacLennan et al., 2003) 
(Obukhanych and Nussenzweig, 2006) (Garcia de Vinuesa et al., 1999) (Taillardet et al., 
2009).   
 
Memory B cells prolonged longevity compared to naive B cells may depend on the properties 
of membrane-bound IgG (mIgG) compared to those afforded by membrane bound IgM 
(mIgM), more frequently expressed by naive B cells. Differences in signalling mIgG and by 
membrane bound IgM mIgM can be explained in part owing to differences in their respective 
sequences. IgM and IgG BCRs have different extracellular, transmembrane (TM) and 
cytoplasmic Fc (fraction crystallisable) domains (Kurosaki et al., 2010a). The Fc region  of 
membrane-bound IgG, is shorter than that of membrane IgM and the extracellular antigen 
binding sites of IgG are linked to the Fc region by flexible hinge region (Arnold et al., 2007). 
Membrane bound IgM, encodes a more rigid Cμ2 domain containing a conserved Asparagine 
(N46)-linked glycosylation site that is absent in the flexible hinge region of membrane IgG 
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(Arnold et al., 2007). The N46 glycosylation of membrane bound μHC and the arginine rich 
tail of λ5 light chain in the pre-BCR are necessary for spontaneous signalling to drive B cell 
development(Ubelhart et al., 2010). N46 glycosylation is not necessary for BCR signalling in 
mature B cells.  
 
While both IgM- and IgG-BCRs require Igα/Igβ heterodimers to engage the B-cell signalling 
apparatus through immunoreceptor tyrosine activation motifs (ITAMs) in the Igα/Igβ 
cytoplasmic domains (Reth, 1992),(Reth, 1992 the extracellular domains of Igα/Igβ 
heterodimer associates better with IgM than with IgG {Radaev, 2010 #4209). The functional 
consequences of preferential association of Igα/Igβ to IgM are not known.  
 
Both mIgM and mIgD have three amino-acid cytoplasmic tails. In contrast, all mIgG subtypes 
have long cytoplasmic tails of 28 amino acids, which are highly conserved across species,(Xu 
et al., 2014) and references there in. Consistent with the idea that IgG cytoplasmic tail is 
necessary to contribute some of the enhance responsiveness of memory B cells are studies by 
Kaisho et al. (Kaisho et al., 1997) and by Martin et al. (Martin and Goodnow, 2002). Kaisho et 
al. (Kaisho et al., 1997)showed that tailless mIgG1 transgenic mice had significantly 
decreased specific antibody responses compared to the transgenic mice expressing the wild 
type mIgG1. Martin et al. (Martin and Goodnow, 2002) showed that a transgenic mouse 
expressing the ectodomain of IgM and TM and cytoplasmic tail of IgG1 generated enhanced 
memory responses compared to the mice expressing the IgM wild type transgene. In addition, 
Waisman et al. (Waisman et al., 2007) showed that IgG1 can exert a unique signalling 
function that can partially replace that of the Igα/Igβ heterodimer to promote B cell survival. 
These results indicate that the isotype of membrane bound Ig determines B cell responsiveness 
and survival and may explain some of the properties of B cell memory responses. 
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Antigen-induced B cell signalling pathways  
 
Antigen binding to the BCR induces signalling which assure entry in the cell cycle, cell 
survival during proliferation, metabolic synthesis to support growth, antigen presentation to 
ensure continuous stimulation and orchestrates B cell fate decisions (Cambier et al., 1994; Dal 
Porto et al., 2004; DeFranco, 1997; Kurosaki et al., 2010b). 
Multivalent antigen binding induces BCR oligomerization and results in signal transduction 
that depends on the non-covalently BCR associated Igα/Igβ heterodimer (Kurosaki et al., 
2010b). After binding of multivalent antigen, the cytoplasmic domains of the BCR 
components also cluster. Then the Igα and Igβ cytoplasmic domains are separated by a 
considerable distance, transitioning from a closed to an open conformation. The open 
conformation is dependent on ITAM phosphorylation, most likely by the action of Lyn, one of 
the Src family PTKs. BCR engagement activates three different families of protein tyrosine 
kinases, Src, Syk and Tec. Activation of Src kinases causes tyrosine phosphorylation of the 
immuno-tyrosine activation motifs (ITAM) in the cytoplasmic domains of Igα/Igβ which in 
turn bind the src homology-2 (SH2) domain of a second kinase, Syk resulting in auto-
phosphorylation.   
BCR clustering occurs in the context of the immunological synapse, which is characterized by 
the central accumulation of BCR and antigen, termed the central supramolecular activation 
cluster (c-SMAC), surrounded by a ring of adhesion molecules (peripheral SMAC, or p- 
SMAC).  Intracellular signaling molecules such as Syk, phospholipase Cγ2 (PLCγ2), and 
Vav1 are co-localized with the initial BCR-containing microclusters (Depoil et al., 2008). 
CD19 is transiently recruited into the BCR clusters and is important for amplifying BCR 
signaling (44). These observations suggested that the micro-signalosomes (probably including 
CD19, Syk, PLCγ2, PI3K, and Vav) are a critical site for the initiation of BCR signaling.  At a 
later time point (15 min after stimulation), the micro-signalosomes dissociate from the BCR 
clusters that reside in the c- SMACs. 
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BCR- signalling results in the triggering of at least four effector pathways: 
PLCγ2/calcium/NFAT pathway; PI3K pathway; IKK/NF-κB pathway and; ERK pathway  
 
PLCγ2/calcium/NFAT pathway 
Syk phosphorylation generates docking domains for the recruitment and activation of several 
other downstream molecules such as the Bruton tyrosine kinase (Btk) and phospholipase Cγ2 
(PLCγ2). PLCγ2 hydrolyzes phosphatydyl-inisitol 4,5 biphosphate (PIP2) to generate two 
important effectors: inositol 1,4,5 triphosphate (IP3) and dyacyl glycerol (DAG). IP3 triggers 
Ca++ mobilization from the ER which when depleted trigger Ca++ import from the exterior. 
Elevation of Ca++ in the cytosol is sensed by Calmodulin which when bound to Ca++ 
activates several molecules including Calcineurin phosphatase and Nuclear-factor of activated 
T cells (NFAT). NFAT requires continuous elevated Ca++ to remain in the nucleus where it 
directs gene transcription including interferon regulatory factor 4 (IRF4) a critical 
transcription factor to direct plasma cell differentiation (Klein et al., 2006; Sciammas et al., 
2006). 
 
PI3K pathway 
Following BCR ligation the cytoplasmic tail of CD19 can be phosphorylated by lyn creating 
binding sites for the SH2 domains of the p85 subunit of PI3K, Vav and Lyn (Brooks et al., 
2000; Fujimoto et al., 2000; Tuveson et al., 1993).  Activation of PI3K requires tyrosine 
phosphorylation of the B cell adaptor for PI3K (BCAP).  CD19  and PI3Kp110δ are necessary 
for the development of peritoneal B1 cells, spleen marginal zone B cells and CD19 is required 
for the development of spleen CD1dhiCD5+ B cells (Akagi et al., 1999; Fruman et al., 1999; 
Janas et al., 2008).  CD1dhiCD5+ B cells are thought to produce IL-10 and therefore 
contribute to immune-regulation (Yanaba et al., 2008).   Thus  the CD19 component of the B 
cell signalossome  also engages regulatory mechanisms .  
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Activated PI3K converts PIP2 into PIP3 which in turn serves as an anchoring domain to 
activate proteins with a plekstrin homology domain such as Akt. Akt activates the mammalian 
target of rapamycin (mTOR) to enhance protein synthesis and cellular metabolism, and 
inactivates FoxO that is necessary to maintain quiescence in resting B cells.  In this way Akt 
helps to drive  proliferation of resting B cells (Xu et al., 2014).   
 
IKK/NF-κB pathway 
Stimulation of the BCR induces PLCγ2 activation which in turn produces DAG.  DAG 
recruits protein kinase C family members that activate CARMA1, Bcl10 and MALT1  
(Thome, 2004) causing activation of the IKK complex (consisting of IKKα, IKKβ, and IKKγ 
or NEMO), thereby phosphorylating IκB and inducing its degradation (Hacker and Karin, 
2006). Degradation of IKB allows NF-κB transcription factors that are retained in the 
cytoplasm by binding to IκB, to translocate to the nucleus.  The NF- κB pathway mediates 
pleotropic functions that control proliferation, survival and differentiation of activated B cells.  
The NF- κB pathway is subject to tight control at many different levels.  For example, the 
association of CARMA1 with Bcl10 and MALT1 depends on its phosphorylation on Ser668 
by PKCβ (Shinohara et al., 2005).  Other Ser/Thr phosphorylation sites in CARMA1 and 
Bcl10 also contribute to the control of NF- κB activation.  In another example, activated IKKβ 
phosphorylates CARMA1 on Ser578 which stabilizes the CARMA1, Bcl10 and MALT1  
complex (Shinohara et al., 2007).  Phosphorylation of Bcl10, on the other hand, causes its 
degradation and inactivation of the CARMA1, Bcl10 and MALT1  complex {Lobry, 2007 
#4311}.   
 
ERK pathway  
DAG generated by PLCγ2 in response to BCR activation facilitates mobilization of both 
guanine nucleotide exchange factors and PKCβ to the membrane.  PKCβ activates RasGRP3 
by Thr133 phosphorylation.  Upon activation, RasGRP3 stimulates the mitogen activated 
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proteins kinases (MAPK) resulting in ErK translocation to the nucleus and transcription 
(Kurosaki et al., 2010b).   
 
The repressible Ig-lambda LC mouse 
 
To elucidate the elements of B cell memory, we engineered a novel experimental system in 
mice, the repressible Ig-lambda LC mouse. In the repressible Ig-lambda LC mouse, all B cells 
contain an antigen receptor of a defined specificity that can be reversibly repressed. In 
addition, its T cells express the transgenic DO.11 TCR specific for an ovalbumin peptide. 
Because it was engineered in a RAG-negative background both B and T cells are monoclonal. 
The lambda light chain expression will be repressed with doxycycline (a tetracycline 
derivative). The control system consists of two elements: a transactivator and a target gene. 
The transactivator acts upon a minimal promoter in the absence of tetracycline (or its 
derivative doxycycline) in the target gene. The minimal promoter (P min) and elements of the 
bacterial tet operon (tetO) are cloned to a structural gene of choice that is to be regulated. In a 
cell line (or mouse) constitutively expressing HSV VP16 fusion protein, which functions as a 
transactivator (tTA), the gene of choice will be expressed so long as there is no doxycycline. 
Doxycycline binds to the tTA, and thus its presence represses gene expression. Several 
transactivator constructs have been developed. We have chosen a transactivator transgenic 
mouse in which expression of the tTA is under the control of the mouse mammary tumor virus 
long terminal repeat (MMTV-tTA). The nature of the reversibly repressible system that 
controls the expression of the light chain makes it particularly suited for the study of the 
immune response. It allows not only an on-off switching, but also a more subtle modulation of 
expression levels. The expression of tetracycline inducible transgenes has been shown to be 
regulated over a range of up to three orders of magnitude in mice expressing MMTV- tTA 
(Hennighausen et al., 1995) (Redfern et al., 1999) and in mice expressing the tTA under the 
control of a MHC II promoter (Witherden et al., 2000). The synthesis of the Ig heavy chain 
will be directed by the knock-in VH17.2.25DJH4 exon targeted to its correct location on the 
 43 
chromosome to allow developmentally and quantitatively correct B cell development, as well 
as isotype switching and somatic hypermutation.   
 
The tetracycline-dependent transactivator system 
Regulation of expression of the lambda gene was engineered using the tetracycline- 
transactivator system. The tetracycline-dependent transactivator system includes an inducible 
promoter that works in a variety of human and murine cells, and whose activity can be 
regulated over five orders of magnitude (Gossen and Bujard, 1992) (Furth et al., 1994) 
(Kistner et al., 1996) (St-Onge et al., 1996). The control system consists of two elements: a 
transactivator and a target gene. The transactivator acts upon a minimal promoter in the 
absence of tetracycline (or its derivative doxycycline) in the target gene. The minimal 
promoter (P min) and elements of the bacterial tet operon (tetO) are cloned to a structural gene 
of choice that is to be regulated. In a cell line (or mouse) constitutively expressing HSV VP16 
fusion protein, which functions as a transactivator (tTA), the gene of choice will be expressed 
so long as there is no doxycycline. Doxycycline binds to the tTA, and thus its presence 
represses gene expression. 
 
Several transactivator constructs have been developed. A transactivator transgenic mouse in 
which expression of the tTA is under the control of the mouse mammary tumour virus long 
terminal repeat (MMTV-tTA) was chosen. Transcriptional activation using the tetracycline 
regulatable system has been shown to be completely abrogated in the presence of doxycycline 
and to be regulated over a range of up to three orders of magnitude in mice expressing the 
MMTV-tTA transactivator (Hennighausen et al., 1995) (Redfern et al., 1999) and in mice 
expressing the tTA under the control of a MHC II promoter (Witherden et al., 2000). The 
MMTV-LTR targets the expression of tTA to lymphocytes and to epithelial cells of the 
secretory organs (Hennighausen et al., 1995) (Redfern et al., 1999). In these models, B cell 
memory will be generated by immunization with a hapten-carrier conjugate (NP-ovalbumin). 
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The NP System  
The hapten (4-hydroxy-3-nitrophenyl) acetyl (abbreviated NP), which induces an immune 
response restricted in idiotype, has been extensively studied (Imanishi and Makela, 1974) 
(Karjalainen, 1980) (White-Scharf and Imanishi-Kari, 1981) (White-Scharf and Imanishi-Kari, 
1982). The VH gene segments encoding these idiotypes, including VH17.2.25 (Loh et al., 
1983), were cloned. Antibodies produced during primary responses to NP are almost 
exclusively of the  type; thus, the 17.2.25 heavy chain produces antibodies specific for NP 
when it combines with a  light chain.  There are only three V segments in the mouse, V1, 
V2 and Vx (Azuma et al., 1981) (Blomberg et al., 1981) (Miller et al., 1981) (Selsing et al., 
1982) (Elliott et al., 1982) (Reilly et al., 1984) (Dildrop et al., 1987) (Sanchez and Cazenave, 
1987). I found that both V1 and V2 bind to NP when associated with VH17.2.25 (Cascalho 
et al., 1996). Whether or not Vx does so as well has not been tested. In addition, the 
VH17.2.25/ antibody does also recognize NIP (4-hydroxy-2-iodo-3-nitrophenyl) acetyl, and 
pNP (4-nitrophenyl) acetyl but with different affinities. 
 
The T cell receptor transgenic system 
The DO.11.10 TCR-transgenic mouse line was developed in Dr. Loh’s laboratory in 1990, 
and since then has been widely studied (Murphy et al., 1990).  Transgenic T cells express the 
TCR from a T cell hybridoma, DO11.10, that recognizes the chicken ovalbumin peptide 
(OVA323-339) in the context of H-2
d
 and H-2
b
 (Murphy et al., 1990) (Liu et al., 1996).  
DO.11.10 TCR T cells mature into CD4-positive T cells in mice expressing H-2
d
.  However, 
in mice expressing H-2
b
, an important fraction of the peripheral T cells expresses neither 
CD4 nor CD8 (Liu et al., 1996). The transgenic TCR expressed in this system can be detected 
by the clonotypic monoclonal antibody KJ1-26 (Marrack et al., 1983) and by a monoclonal 
antibody that binds Vβ8, F23.1.  In this proposal, DO 11.10 is abbreviated DO.11. 
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Abstract 
 
Survival of mature B cells is thought to depend on the B cell receptor signaling (BCR) because 
ablation of either Heavy chain (HC) expression or BCR signaling causes B cells to rapidly 
disappear.  Whether a complete BCR is required for survival of mature B cells is not known.  
To address this question we generated a mouse in which we can repress the expression of a 
transgenic Ig Light chain (IgL) by doxycycline (IgL repressible mouse).  Repression of IgL 
abrogated BCR expression.  Surprisingly, however, IgL-negative B cells survived longer than 
14 weeks, expressed signal-competent HC on the cell’s surface and active unfolded protein 
response (UPR) factors.  Like post-germinal center B cells, IgL-negative B cells were small 
lymphocytes, not dividing and expressed Bcl-6.  Our results indicate that expression of 
unpaired HC as it may occur as a consequence of antigen ligation, somatic hypermutation or 
receptor editing, facilitates the survival of cells either by inducing receptor signaling, or by 
inducing UPR and/or the expression of survival genes such as Bcl-6.  
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Introduction 
 
The development and survival of mature B cells is thought to require stable expression of 
surface immunoglobulin (Ig) (Lam et al., 1997) and expression of functional Igαβ dimer 
(Kraus et al., 2004).  Lam et al. (Lam et al., 1997) and Kraus et al. (Kraus et al., 2004) showed 
that repression of heavy chain (HC) and consequently of surface Ig expression causes death of 
mature B cells and inferred that survival depends on B cell receptor (BCR) signaling through 
the Igαβ dimer, much as the T cell receptor is required for T cell survival (Anderson et al., 
1999).  Whether instead the HC itself might promote survival independently of the BCR was 
not formally considered.  We sought to test this question. 
 
Expression of membrane-bound HC drives early B cell differentiation even in the absence of a 
complete surrogate light (SL) chain and conventional light (L) chains. This idea is supported 
by the studies of Schuh et al. (Schuh et al., 2003) who found that a transgenic µHC reaches the 
cell surface in the absence of the SL chain component λ5 and conventional L chains induce 
IL-7-dependent cell growth and promote in vivo differentiation of pro-B cells. Similarly, 
Galler et al. (Galler et al., 2004) showed that µHC signals terminate the expression of terminal 
deoxynucleotidyl transferase and downregulate the expression of the recombination activation 
genes 1 and 2 (RAG1 and RAG2) in the absence of SL and L chains. 
 
B cells of camels, sharks, and ratfish produce HCs that cannot pair with LCs (Conrath et al., 
2003).  In these species (Conrath et al., 2003) and when expressed in mice (Zou et al., 2005), 
unpaired HCs appear to drive B cell development and contribute to HC-only antibodies which 
make up to 75% of the serum Ig (Conrath et al., 2003).  Synthesis of HC-only antibodies may 
depend on some HC unique features including VH FR2 domain adaptations and lack of a CH1 
domain.  These features antagonize binding to LCs and possibly to the chaperone 
immunoglobulin HC binding protein (BiP) that retains unpaired HCs in the endoplasmatic 
reticulum (ER) (Conrath et al., 2003) thus enabling trafficking from the ER to the cell surface 
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in the absence of LC. Synthesis of HC–only antibodies suggests that unpaired HCs may 
sustain B cell development and mature B cell survival.  
 
In light of these properties of HC we questioned whether murine HC expressed without LC 
might sustain mature B cell survival. To test this concept, we generated a novel experimental 
system in mice: the IgL-repressible mouse.  In the IgL-repressible mouse, expression of LC 
and of surface BCR can be abrogated by feeding the mice doxycycline.  Expression of HC 
remains unaffected in these mice.  From the phenotype of the IgL-repressible mouse, we here 
report that, contrary to expectations, mature B cells survive repression of LC and that 
continued expression of HC alone drives long-term survival of B cells.  We also report that 
HC is expressed on the surface of cells and can associate with Igαβ dimers to yield a 
functional complex that promotes survival. In contrast to studies by Corcos et al. (Corcos et 
al., 2001) showing that truncated heavy chains that lack the VH exon are expressed unpaired 
on the surface of B cells, B cells of the IgL-repressible mouse express the full-length protein. 
Although truncated heavy chains do not sustain survival of B cells (Corcos et al., 2001) our 
studies indicate that expression of full-length HC does.  These findings may explain how some 
cells of B lineage (e.g., plasma cells or neoplastic B cells) survive with little or no surface Ig. 
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Materials and Methods 
 
Mice 
The IgL-repressible mouse has monoclonal B and T cell compartments.  Because the mice are 
on a recombination activation gene 1 negative background (RAG1-/-), no endogenous B or T 
cell antigen receptors are produced.  Instead, T cells express the transgenic DO.11.10 TCR 
(Liu et al., 1996; Loh et al., 1983; Murphy et al., 1990), while B cell immunoglobulin is 
encoded by a combination of knock-in μHC gene (VH17.2.25) (Cascalho et al., 1996) and a 
λLC transgene (Young et al., 1994).  The transgenic T cell receptor is specific for an 
ovalbumin peptide (OVA aa323-aa339) and the combined transgenic knock-in B cell receptor 
is specific for the hapten 4-hydroxy-3-nitrophenyl acetyl (abbreviated NP) and its derivatives 
(Cascalho et al., 1996).  Expression of λLC is regulated by the availability of doxycycline.  In 
the absence of doxycycline a transactivator binds the minimal promoter and drives λLC 
expression (Figure 1A). 
 
The LC gene was engineered using the tetracycline-inhibitable transactivator system (Gossen 
and Bujard, 1992).  This system consists of a transactivator and a target λLC transgene.  The 
transactivator or tTA (HSV VP16 fusion protein) is under the control of the mouse mammary 
tumor virus long terminal repeat promoter (MMTV-tTA) and is constitutively expressed.  The 
MMTV-LTR targets the expression of tTA to lymphocytes and to epithelial cells of the 
secretory organs (Hennighausen et al., 1995; Redfern et al., 1999). 
 
The transactivator (tTA) in the absence of tetracycline (or its derivate doxycycline) acts upon 
the λLC transgene minimal promoter (Pmin) promoting transcription.  Doxycycline binds the 
tTA, preventing it from binding Pmin (Hennighausen et al., 1995; Redfern et al., 1999) and 
effectively repressing λLC expression. 
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Tetracycline-responsive 1 transgene 
The repressible lambda construct puts the λLC gene under the control of a tetracycline and 
transactivator-responsive promoter (TetO).  The λ gene was obtained by Eco R1 digest of the 
C2 plasmid (a kind gift of Dr. Fay Young (Young et al., 1994)).  This fragment contains the 
lambda endogenous promoter and the VλJλ rearrangement linked to Cλ in a genomic 
configuration.  The promoter region was subsequently excised by further digestion with Sex 
A1, which cuts 15 base pairs upstream of the start codon ATG.  The 5.8 Kb fragment was then 
blunted and cloned at the PvuII site of the pBI-EGFP plasmid (Clontech, cat#6154-1).  The 
final plasmid puts the λ gene under the control of a TetO regulatory element linked to the 
hCMV minimal promoter.  Because the λ gene lacks an intronic enhancer and there is no 3’  
enhancer in this construct, transcription depends on the binding of a transactivator to the TetO 
element.  EGFP expression which in the pBI-EGFP plasmid is under the control of a TetO 
regulatory element was lost upon breeding the founder mice.   
 
Generation of the IgL repressible mouse by breeding 
The λ-repressible founders were mated to the MMTV-tTA mouse and to mice of the 
following genotype: RAG1-/-, VH T/ VH T, DO11 TCR, H-2
d/d
.  The repressible Ig mice, 
obtained from the previous crossings, have the following phenotype: RAG1-/-, VH T/ JH +,  
ind, tTA, DO11-TCR, H-2
b/b
.  The studies here discussed were performed with mice derived 
from two independent founders. 
 
Animal care and doxycycline treatment  
All mice were between 1 to 3 months of age and kept in a specific pathogen-free facility at the 
Mayo Clinic.  All animal experiments were carried out in accordance with protocols approved 
by the Mayo Clinic Institutional Animal Care and Use Committee.  IgL repressible mice were 
fed doxycycline diet (grain based) 200mg/Kg (S3888) (Bio-Serv, Frenchtown, NJ). 
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Genotyping 
DNA was extracted from mouse tails according to standard protocols (Cascalho et al., 1996).  
Genotyping was done by PCR amplification of tail DNA with thermoprime plus DNA 
polymerase (ABgene, Rochester, NY) and 12 pmol of each primer for 40 cycles using an 
Icycler (Biorad, Hercules, CA) thermocycler.  H chain knock-in  (VH17.2.25 DJH4) Forward-
5’AAGTTCAGCTGCAGCAGTCTGG 3’; reverse-5’GGGACAAATATCCAAGATTAGTC 
3’, 450 base pairs, Tm 51°C; Lambda 1 LC Forward-5’ 
GCCTTTCTACACTGCAGTGGGTATGCAACAAT 3’; Reverse- 5’ 
AGCCACTYACCTAGGACAGTSASYTTGGTTCC 3’, 500 base pairs, Tm 60°C; TTA 
Forward-5’  AGAGAATGCATTATATGCACTCAGCG 3’; Reverse- 5’ 
AGACCCGTAATTGTTTTTCGTACGCG 3’, 280 base pairs, Tm 55°C; TCR Forward-5’ 
CAGGAGGGATCCAGTGCCAGC  3’; Reverse-5’TGGCTCTACAGTGAGTTTGGT, 300 
base pairs, Tm 52°C; I-A
b
 Forward-5’ CATAGCCCCAAATGTCTGACCTCTGGAGAG 3’; 
Reverse- 5’ AGTCTTCCCAGCCTTCACACTCAGAGGTAC 3’, 200 base pairs, Tm 60°C; 
and I-A
d
 Forward-5’ CATAGCCCCAAATGTCTGACCTCTGGAGAG 3’, Reverse- 5’ 
CATGGGCATAGAAAGGGCAGTCTTTGAACT 3’, 200 base pairs, Tm 60°C.  
 
Cell lines and culture conditions 
Ag8.H cells were grown in complete RPMI (RPMI 1640 medium supplemented with 50 U/ml 
penicillin, 50 µg/ml streptomycin, 5% FCS, 1 mM sodium pyruvate and 2 mM L-glutamine.  
Ag8.H-Ig transfectants were selected in complete RPMI supplemented with 1 mg/ml G418 
(PAA, Pasching, Germany), whereas Ag8.H-Ig expressing µHC was cultured in complete 
RPMI with 1 mg/ml G418, 1.25 µg/ml mycophenolic acid, 250 µg/ml xanthine, 100 μM 
hypoxanthine and 16 μM thymidine.  All cell lines were maintained at 37°C and 5% CO2 in a 
humidified incubator. 
 
The Ag8.H-Ig cell line was generated to analyze the cell surface transport of B cell receptor 
(BCR) complexes by transfection of Ag8.H, a subclone of the murine immunoglobulin-
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negative plasmayctoma cell line Ag8.653 (Kearney et al., 1979). Murine Igα, required for 
surface transport of BCR complexes (Hombach et al., 1988), was amplified by PCR from 
cDNA of the murine lymphoma B-cell line CH27 with an appropriate forward 
(TTGGATCCACGATGCCAGGGGGTCTAGA, containing a BamHI restriction site) and 
backward primer (TTGAATTCCAGTCATGGCTTTTCCAGCT, containing an EcoRI 
restriction site).  The Igα fragment was cloned into the BamHI and EcoRI site of the 
mammalian expression vector pEF1/myc-His (Invitrogen, Karlsruhe, Germany) and 
transfected by electroporation (250 V, 960 µF; (Keyna et al., 1995)).  Subsequently, pµ.gpt 
encoding an IgL-pairing and functional µHC with the same VH17.2.25DJH4 variable exon of 
the HC expressed in the repressible Ig mouse  (Jack et al., 1992) were transfected in Ag8.H-
Ig by electroporation.  Stable cell clones were established by limiting dilution and analysed 
by flow cytometry. 
 
Flow Cytometry  
Organ cell suspensions were prepared by pushing the organ through 0.70 m mesh (spleens 
and lymph nodes) or by passing the tissue repeatedly though a 27G needle (bone marrow).  
White blood cells were isolated using Ficoll-Plaque (GE Healthcare) gradient and cells 
counted with a Coulter counter (Beckman Coulter, Miami, FL).  Surface staining of 
splenocytes were done as described (Cascalho et al., 1996); for intra-cytoplasmic staining 
splenocytes were fixed in PBS supplemented with 2% paraformaldehyde at 4C for 1 hour, 
permeabilized in 1 ml of 0.2% Tween 20 in PBS and in 1 ml 0.1% NaN3 with 2% fetal calf 
serum.  For membrane staining of cultured cells 5 x 10
5
 cells were incubated for 30 min on ice 
in PBS supplemented with 2% FCS and 0.1% NaN3 with the appropriate amount of antibodies.  
For cytoplasmic staining of cultured cells, 5 x 10
5
 cells were fixed in 4% paraformaldehyde in 
PBS at RT for 10 min, permeabilized with 0.1% Tween20 at 37°C for 15 min and stained at 
RT for 15 min with the appropriate amount of antibodies.  Data analyses were performed 
using a FACSCalibur (BD Biosciences, San Jose, CA) and CellQuest
TM
 software (v4.0.2).   
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Antibodies 
Antibodies used were biotin-labelled, goat IgG directed against the murine IgM (H+L), 
purchased from Southern Biotech (Birmingham, AL), from Becton Dickinson (Franklin 
Lakes, NJ) APC (Allophycocyanin)-labeled anti-mouse CD19 (1D3), biotin labeled anti-
mouse Ig, λ, 2 & 3 LC (R26-46), R-Phycoerythrin (R-PE)-conjugated rat anti-mouse CD23 
(FcεRII) (B3B4) monoclonal antibody, Fluorescein Isothiocyanate (FITC)-conjugated rat anti-
mouse CD21/CD35 (CR2/CR1, CD21a/CD21b) (7G6) monoclonal antibody, FITC-
conjugated rat anti-mouse CD24 (Heat Stable Antigen) (M1/69) monoclonal antibody, biotin-
conjugated mouse anti-mouse IgD
a
 (Igh-5a, Igh-5.4) (AMS 9.1) biotin-conjugated mouse anti-
mouse IgD
b
 (Igh-5b) (217-170) for B6 mice, and FITC-conjugated rat anti-mouse 
CD45R/B220 (RA3-6B2) monoclonal antibody.  Biotin-labeled antibodies were detected with 
Streptavidin-PE-Cy5 (BD Biosciences Pharmingen, Franklin Lakes, NJ).  Ki67 was detected 
with rat anti-mouse Ki67 (TEC-3, DAKO) antibody in tissue sections. 
 
Unconjugated affinity purified goat antibodies against mouse IgM (H+L) (Birmingham, AL) 
were labelled with the Cy5 labelling kit from Amersham Biosciences (Freiburg, Germany).  
The monoclonal mouse IgG1, antibody 24C2.5 against the intracellular tail of mouse Ig 
was previously described (Mielenz et al., 2003).  
  
Tunel assay 
Done with an apoptosis detection kit, ApopTag Red in Situ, according to the manufacturer’s 
instructions (Chemicon, Int) 
 
Ca2+ influx 
Ca2+ influx studies were performed by incubating splenocytes with 5M INDO-1 AM 
(Invitrogen, Carlsbad, CA) for 30 minutes at room temperature and then labelled with anti-
CD19 and anti-B220 antibodies for 30 min at 4°C.  Cells were kept at 37°C for 2 min before 
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adding unlabeled the stimulus: polyclonal unlabeled goat anti-mouse IgM (H+L) (200g/ml) 
(Southern Biotech, Birmingham, AL), polyclonal unlabeled goat anti- mouse IgM (Fab’)2 
(25g/ml) (Southern Biotech, Birmingham, AL), polyclonal unlabeled goat anti-mouse 
lambda (λ chain specific) (200g/ml), polyclonal unlabeled total goat anti-mouse IgG were 
purchased from Southern Biotech, Birmingham, AL. Ionomycin was obtained from 
Calbiochem, MERK KGaK, Darmstadt, Germany.  Data collected and analyzed on a 
cytometer (LSR II, Becton and Dickinson, Franklin Lakes, NJ) with Flow Jo software.  The 
results are shown in indo1-violet/indo1-blue ratio. 
 
RT-PCR and Real Time PCR 
RNA was extracted using Qiagen RNeasy Kit (Valencia, CA, cat# 74104) according to the 
manufacturer’s instructions.  The RNA yield was measured with the nanodrop ND-3300 
Fluorospectrometer (Wilmington, DE).  Reverse transcription was performed using Invitrogen 
ThermoScript RT-PCR System (Carlsbad, CA, cat# 11146-016) also according to the 
manufacturer’s instructions.  Real time PCR was performed in the Roche Light cycler using 
QuantiTect SYBR Green PCR Kit from Qiagen (Valencia, CA) according to the 
manufacturer’s instructions.  The cDNA was amplified using the following primers: Pax-5 F 
CTACAGGCTCCGTGACGCAG and Pax-5 R TCTCGGCCTGTGACAATAGG (annealing 
65°C 439bp), VpreB F GTCTGAATTCCTCCAGAGCCTAAGATCCC and VpreB R 
CAGGTCTAGAGCCATGGCCTGGACGTCTG (annealing 60°C 400bp), Lambda5 F 
GGGTCTAGTGGATGGTGTCC and Lambda5 R CAAAACTGGGGCTTAGATGG 
(annealing 60°C 205bp), VH F GGGATATCCACACCAAACATC and VH R 
CATACACAGAGCAACTGGACA (annealing 50°C 1785bp), myc for 
CAGCTCTGGAGTGAGAGGGGCTTT and myc rev 
GTAAGTTCCAGTGAGAAGTGTCTG (annealing 59°C 150bp), Ire1 F 
AGAAGCTACCTGTTGGCCGTTGTA and Ire1R CATCCTGGAAGAACTGGAGCTCCT 
(annealing 59°C 150bp), mChopRT3 TGCAGGGTCACATGCTTGGC and mChopRT2 
GCCTGACCAGGGAGGTGGAG (annealing 54°C 150bp), Edem1 F 
ATCCGAGTTCCAGAAGGCAGT and Edem1 RV GCTTCCCAGAACCCTTATCGT 
(annealing 53°C 150bp), mBiPRT1 GATTCCAAGGAACACTGTGGTA and mBiPRT3 
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CCAGTCAGATCAAATGTACCC (annealing 52°C 150bp), λ T9 F 
CCAGGCTGTTGTGACTCAGGA and λ tg CDR2 R GGAGCTCGGTTGTTGGTACCA 
(annealing 54°C 150bp), AID3 ATCTCAGACTGGGACCTGGAC and AID5 
CCTTGCGGTCTTCACAGAAGT (annealing 53°C 174bp), Xbp1u F 
AGCACTCAGACTATGTGCACCTCT and Xbp1s R 
GGACATTTGAAAAACATGACAGGG (annealing 58°C 163bp), Xbp1s F 
TGCTGAGTCCGCAGCAGGTGCA and Xbp1s R GGACATTTGAAAAACATGACAGGG 
(annealing 58°C 150bp), BLIMP1 F TGACTTTGTGGACAGAGGCCGAGT and BLIMP1 R 
CTGTTGTTGGCAGCATACTTGAAA (annealing 58°C 150bp), Bcl6 for 
TGCAGGAAGTTCATCAAGGCCAGT and Bcl6 rev TTCTCAGTGGCATATTGTTCTCCA 
(annealing 58°C 150bp) and finally β-actin F CCTAAGGCCAACCGTGAAAAG and β -actin 
R TCTTCATGGTGCTAGGAGCCA (annealing 54°C 600bp). The Real time primers where 
Lambda 1 CDR2 GGAGCTCGGTTGTTGGTACCA and Lambda TG Fw 
CCAGGCTGTTGTGACTCAGGA (173bp) and LCM β -actin 1 
AGCTGGCCGGGACCTAACTGACTA and LCM β -actin 2 
AGCCGTGGCCATCTCTTGCTCGAA (151BP). 
 
Immunohistochemistry 
Done essentially as described in João et al. (João et al., 2004).  The primary antibodies used 
were: Unlabeled goat anti-mouse lambda LC and FITC-conjugated goat F(ab’)2 anti-mouse 
IgM (H+L) were purchased from Southern Biotech (Birmingham, AL), AP was purchased 
from Cappel (Irvine, CA), rat anti-mouse CD19 (1D3) purchased from BD Biosciences-
Pharmingen (Franklin Lakes, NJ) and rat anti-mouse CD180 (RP105) (RP/14) purchased from 
Serotec (Raleigh, NC).  The secondary/tertiary antibodies used were: Rhodamine-conjugated 
Donkey F(ab’) 2 anti-rat IgG (H+L) from Jackson ImmunoResearch (West Grove, PA), FITC-
conjugated rabbit F(ab’) 2 anti-goat IgG from ICN/Cappel (Irvine, CA) and FITC-conjugated 
goat F(ab’) 2 anti-rabbit IgG from ICN/Cappel (Irvine, CA).  Slides were examined on a 
fluorescence microscope (Leica DMRD, Bannockburn, IL).  Digital images were obtained 
utilizing a high-resolution CCD digital camera (SPOT II, Diagnostic Instruments, Sterling 
Heights, MI) mounted to the microscope and SPOT II software.   
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Immunoprecipitation and Western Blot analysis of splenocytes 
Spleens were harvested and cell suspensions prepared by pushing homogenates through a 70 
µm nylon mesh.  Red blood cells where depleted using Ficoll-Paque (GE Healthcare).  B cells 
were isolated using the MACS column (Miltenyi Biotec, Auburn, CA) and the B cell isolation 
kit (Miltenyi Biotec, Auburn, CA) yielding 3 to 10x10
6
 cells per preparation.  Protein 
concentration was determined using BCA Protein Assay Kit (Pierce, Rockford, IL) as per the 
manufacturer’s instructions.  When surface biotinylation was performed, 10x107 cells in 250µl 
PBS were incubated with 4 mg of Sulfo-NHS-LC-Biotin (Pierce, Rockford, IL) for 30 minutes 
at RT.  Cells were washed with PBS supplemented with 100 mM glycine to quench and 
remove excess biotin.  Cells were lysed in BEACH buffer (50 mM Tris-HCl pH 8.0, 150 mM 
NaCl, 5mM EGTA, 5 mM EDTA, 15 mM MgCl, 60 mM -glycerolphosphate, 1 mM DTT, 
0.1 mM Na-vanadate, 0.1 mMNaF, 15 mM p-nitrophenyl phosphate, 1% Triton X-100 and 1 
proteinase inhibitor tablet from Roche, Basel, Switzerland) for 30-45 min on ice.  Cell lysate 
corresponding to 3 to10x10
6
 cells was centrifuged at 14000 rpm at 4°C for 20 min and the 
supernatant was collected for analysis.  
 
For immunoprecipitation, 35 l of beads were coated with 1-5g of the appropriate antibody 
for 2h at 4°C with agitation.  Coated beads were incubated with the cell lysate obtained from 3 
to10x10
6
 cells, for 2h at 4°C with agitation and after washing, extracted with 35 l of 2X 
sample buffer at 100°C for 5 min.  Samples were analyzed on a 10%SDS PAGE and blotted 
onto an Immobilon–P 0.45 m PVDF membrane (Millipore, Bedford, MA).  The membrane 
was blocked with 5% non-fat milk in PBST for 45 min at room temperature.  Blotted proteins 
were revealed with a primary antibody, incubated overnight at 4°C followed by washing and a 
secondary antibody incubated for 45 min at RT.  After washing with PBS, blots were 
developed using lumiglo reagent purchased from Cell signaling (Danvers, MA). 
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The primary antibodies were HRP or biotin conjugated, affinity purified goat anti-mouse IgM, 
human absorbed (Southern Biotech, Birmingham, AL), rabbit IgG anti-mouse lambda LC 
(ICN0029) and goat anti-mouse IgG ( chain specific) (Southern Biotech, Birmingham, AL).  
The secondary reagents were HRP-conjugated Protein A (Amersham Biosciences, Pittsburgh, 
PA), HRP-conjugated anti-mouse Ig (H&L) and HRP-conjugated anti-goat Ig (Cell Signaling, 
Danvers, MA).  Beads for immunoprecipitation were Streptavidin immobilized on 4% beaded 
agarose (Sigma, St. Louis, MO), Protein A agarose (Sigma, St. Louis, MO) and Protein G 
(Pharmacia). 
 
Western Blot analysis of cultured cells 
1 x 10
6 
cells were washed in 2 x PBS and lysed on ice for 30 min with NET buffer (150 mM 
NaCl, 1 mM sodium vanadate, 50 mM NaF, 0.5% Nonidet P-40, 1mM PMSF, 5 mM EDTA, 
25 mM Tris-HCl (pH 7.4)).  Solubilized cells were centrifuged (10.000 x g for 10 min at 4°C) 
and supernatants analyzed by SDS-Page according to Laemmli et al.  (Laemmli, 1970).  Broad 
Range Marker (Bio-Rad, Munich, Germany) was used as molecular weight standard.  
Separated proteins were O/N transferred to nitrocellulose membranes (Schleicher & Schuell, 
Dassel, Germany) in 25 mM Tris, 192 mM glycine and 20% methanol at 4°C.  Membranes 
were blocked with 5% non-fat milk in TBST pH 7.5 (25 mM Tris-HCl, 150 mM NaCl and 
0.1% Tween20) for 1h.  The blots were incubated with HRP-conjugated goat anti-mouse IgM 
(H+L)  (Southern Biotech, Birmingham, AL) diluted 1:6.000, for 1h.  Blots were washed for 4 
x 10 min in TBST and developed with the ECL method. 
 
ELISA 
Total splenocytes where lysed using Beach Buffer.  Serial dilutions of lysates were incubated 
overnight at 4C in ninety-six well flat bottom microtiter plates (Nunc-Immuno 96 Micro well 
– Maxisorp, Bioscience, San Diego, CA) coated with 2 g/ml of unlabeled goat anti-mouse 
lambda (Southern Biotech, Birmingham, AL) and blocked with PBS supplemented with 0.1% 
gelatin and 0.1% Tween20.  Lambda LC was revealed with HRP-conjugated goat anti-mouse 
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lambda (Southern Biotech, Birmingham, AL) and developed with ABTS.  Plates were read at 
405 nm at 5, 10 and 20 min on a microplater reader (Power Wave X, Bio-Tek Instruments, 
Winooksi, VT) and analyzed using the software KC4 – Kineticalc for Windows.  
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Results  
 
The IgL repressible mouse  
The IgL repressible mouse is bred onto a recombination activation gene-1 negative 
background (RAG1-/-).  B cells in this mouse express a monoclonal BCR consisting of a 
constitutively expressed knock-in μHC (VH17.2.25) (Cascalho et al., 1996) and of a DOX-
repressible 1LC transgene (Young et al., 1994).  Expression of λ1LC transgene is driven by 
the binding of a tetracycline-controllable transcription factor (tTA) to the minimal tet promoter 
(Pmin) (Gossen and Bujard, 1992; Hennighausen et al., 1995; Redfern et al., 1999).  The 
activity of the tTA can be abolished by the addition of tetracycline or its derivative 
doxycycline (Figure 1A).  Since the tTA gene is under the control of the mouse mammary 
tumor virus long terminal repeat promoter (MMTV-tTA), the expression of tTA is constitutive 
and targeted to lymphocytes and to epithelial cells of the secretory organs (Hennighausen et 
al., 1995; Redfern et al., 1999).  The transgenic BCR is specific for the hapten (4-hydroxy-3-
nitrophenyl) acetyl (abbreviated NP) and its derivatives (Cascalho et al., 1996).  T cells in the 
IgL-repressible mouse are also monoclonal and express the DO.11 10 αβ TCR (Murphy et al., 
1990). 
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FIGURE 1A: Proposed model of λLC repression in IgL-repressible mice.  Briefly: in the absence of 
doxycycline, the constitutively expressed transactivator (tTA) binds the tet promoter and drives expression of 
λLC; when doxycycline is present it binds the transactivator (tTA) and prevents it from binding to the tet 
promoter effectively abrogating λLC expression.  The HC continues to be expressed following doxycycline 
treatment and reaches the surface with Igα/β. 
 
Doxycycline treatment represses LC production 
We first determined whether administration of DOX to the IgL-repressible mouse inhibits 
expression of λLC. λLC protein could not be detected by Western Blot analysis of splenocytes 
isolated from mice that were fed doxycycline for four weeks (Figure 1B, lane 3).  ELISA of 
homogenates (including cytoplasmic and membrane bound protein) obtained from purified B 
cells confirmed the absence λLC in DOX-treated IgL-repressible mice.  ELISA limit of 
detection of λLC was 2ng/ml. when all B cells expressed λLC (in the QM mouse), we 
measured 64.6 ng/ml or 23 ng/million B cells. We detected only 5.5 ng λLC /ml in control 
C57BL/6 B cells corresponding to 8.5% of the QM values, which is in linewith the fact that 
only 5-10% of B cells in B6 mice express λLC. 
Repressible-Ig mouse B cells can only express λLC. In the absence of DOX, we detected 19.0 
ng λLC/ml or 1.5 ng λLC/million B cells, indicating that B cells in the repressible-Ig mouse 
produce 15-fold less λLC than QM B cells. The assay could not detect λLC above background 
levels in as many as 0.5 X 10
6
 B cells obtained from a repressible-Ig mouse following DOX 
treatment. This result indicated that DOX-treated repressible-Ig B cells produced at least 32-
fold less λLC as aQM B cells and had at least 3-fold less λLCthan non DOX-treated 
repressible Ig B cells. 
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FIGURE 1B: Western Blot analysis of λLC expression.  Splenocyte cell lysates were obtained from B6 or from 
pooled IgL-repressible mice not fed or fed doxycycline, as indicated. Lysates were immunoprecipitated with goat 
anti-mouse λLC antibody and revealed with the same antibody on Western Blots.  Equal amounts of protein were 
loaded in each well (0.5mg). 
 
To determine the extent of transcription repression of the λLC gene in mice fed doxycycline, 
we performed RT-PCR with primers that were specific for cDNA.  We failed to detect LC 
mRNA (Figure 1C). 
 
FIGURE 1C:  RT-PCR analysis of 1 LC and HC mRNA obtained from total splenocytes of IgL-repressible 
mice fed or not fed doxycycline or from QM mice, as indicated.  Figure shows the absence of detectable λLC 
mRNA in doxycycline-treated mice. μHC and -actin were used to control the quantity and integrity of cDNA.  
cDNA obtained from 1 μg of RNA was PCR amplified from serial dilutions (1:1, 1:5 and 1:25), for 35 cycles.  
 
To determine if repression of λLC protein expression effectively abrogated LC function as part 
of the BCR, we compared changes in the level of intracellular free Ca
2+
 in B cells stimulated 
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with anti-LC antibody.  While B cells from IgL-repressible mice not treated with 
doxycycline responded to anti-LC antibody by quickly increasing the intracellular Ca2+ 
(Figure 1D, blue line), B cells from mice treated with doxycycline did not (Figure 1D, red 
line).  These results indicate that doxycycline treatment generated B cellsfunctionally lacking 
LC, which we will refer to as “LC–negative B cells.” 
 
FIGURE 1D: Flow cytometry analysis of Ca
2+
 influx in splenocytes obtained from IgL repressible mice treated 
(below) or not treated (above) with doxycycline.  Histograms represent ratio of fluorescence intensities of Indo 
1AM bound to Ca2+ / free Indo 1AM over time (seconds).  Arrows denote the time the stimulus was added, goat 
anti-mouse λ LC antibody (blue) or goat IgG control (red).  LC-repressed splenocytes failed to generate a rapid 
Ca
2+
 influx peak following LC cross-linking (bottom diagram). 
 
B cells survive and continue to express membrane bound HC upon LC repression   
Expression of surface BCR is thought to require the correct assembly of heavy and light 
chains.  Hence, we questioned whether repression of LC affects surface HC expression on 
splenic B cells isolated from doxycycline-treated mice.  As expected from the analysis of λLC 
expression by Western Blot analysis, we detected surface λLC on all CD19-positive 
0 100 200 300 400
Time
24K
25K
26K
R
a
ti
o
: 
In
d
o
 1
 (
V
io
le
t)
-A
/I
n
d
o
 1
 (
B
lu
e
)-
A
+DOX
0 100 200 300 400
Time
24K
25K
26K
27K
R
a
ti
o
: 
In
d
o
 1
 (
V
io
le
t)
-A
/I
n
d
o
 1
 (
B
lu
e
)-
A
-DOX
 79 
splenocytes from mice not fed doxycycline (Figure 2A, first row), but not from mice fed 
doxycycline.  Only about 5% of B6 splenocytes expressed λLC (Figure 2A, first row, diagram 
on right).  However, despite the complete repression of LC expression in mice fed 
doxycycline, we detected HC in the cytoplasm as well as on the surface of B cells (Figure 
2A, second and third row).  Surface HC was reduced by 10-fold in B cells that lack LC 
(Figure 2A, second row), but cytoplasmic HC was not. 
 
FIGURE 2A:  Flow cytometric analysis of splenocytes from IgL repressible mice fed or not fed doxycycline and 
B6 control, as indicated.  The left column represents the lymphocyte gate on the light scatter plot used in the 
analysis.  The three columns to the right represent the fluorescence intensity plots of lymphocyte gated events 
stained with labeled antibodies, as indicated.  Surface and cytoplasmic µHC were detected with a goat anti-mouse 
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IgM(H+L), all other antibodies were rat anti-mouse monoclonal.  Mature (MB) and immature (IB) B cells were 
identified in fluorescence intensity plots shown in row 4 obtained from lymphocyte and CD19-positive gated 
events.  Marginal zone (MZ) and follicular (FO) B cells (fifth row) were identified in fluorescence intensity plots 
shown in row 5 obtained from lymphocyte and B220-positive gated events.  The figure shows that λLC-positive, 
surface CD19-positive B cells disappear in mice treated with doxycycline but CD19-positive, λ LC-negative cells 
survive (upper row) expressing both surface (second row) and cytoplasmic (third row) HC.  Immature and 
marginal zone B cells are absent in doxycycline treated IgL repressible mice.  Only 5% (circa) of CD19-positive 
B cells in B6 mice are λ LC positive. 
 
The presence of cells with markers characteristic for B cells (CD180, CD19 and µHC) could 
be verified in the absence of LC in histological sections of spleen obtained from IgL-
repressible mice fed doxycycline (Figure 2B).  These data show that LC-negative cells express 
CD180, CD19 and µHC indicating that B cells survived repression of LC.  To determine 
which subsets of B cells survived repression of LC we distinguished mature 
(CD19
+
/CD24
lo
/IgD
hi
) immature (CD19
+
/CD24
hi
IgD
lo
), marginal zone 
(B220
+
/CD21
hi
/CD23
lo
) or follicular B cells (B220
+
/CD21
lo
/CD23
hi
) by flow cytometry 
analysis of splenocytes obtained from IgL-repressible mice fed or not doxycycline.  Figure 2A 
fourth row shows that immature B cells (IB) and marginal zone B cells (MZ) disappeared 
following LC repression.  The surviving B cells included follicular B cells, the numbers of 
which decreased from 1.4 million to 0.3 million, 4 weeks after LC repression.  
 
Pre-B cells that express HC do so in conjunction with surrogate LC (Melchers et al., 1993).  
The surrogate LC is composed of 5 and V pre-B proteins, and these together with HC form 
the pre-B cell receptor that reaches the cell surface (Iglesias et al., 1993; Melchers et al., 
1993).  Because the pre-B cell receptor is thought to sustain survival of pre-B cells (Rajewsky, 
1996), we asked whether B cells surviving repression of LC express a pre-BCR.  Figure 2C 
shows that mRNA for the surrogate LC components Vpre-B and 5 was absent in peripheral 
LC-positive as well as in LC-negative B cells.  These results were corroborated by flow 
cytometry using antibodies specific for pre-BCR components (not shown) and indicate that 
surface LC-negative B cells were not pre-B cells.  Since surviving B cells expressed CD19 and 
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the Pax-5 transcription factor (Figure 2C), and plasma cells do not (Delogu et al., 2006), our 
results also indicate that LC-negative B cells were not terminally differentiated.   
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FIGURE 2B:  Frozen sections obtained from spleen of IgL repressible mice fed (right) or not fed (left) 
doxycycline.  Sections were co-stained with anti-λ (FITC-conjugated) (second row) and anti-CD180 antibodies 
(Rhodamine-conjugated) (third row).  Sections shown in the fourth row were stained with an anti-CD19 antibody 
(FITC-conjugated) and in the fifth row, with an anti-IgM(H+L) antibody (FITC-conjugated), as indicated.  All 
sections were also stained with DAPI to identify nuclei as shown in the first row.  Figure shows that λ LC 
expression is abrogated by doxycycline and that surviving B cells that λ LC repression express CD180, CD19 and 
HC.   
 
 
FIGURE 2C:  RT-PCR analysis of Pax-5, Vpre-B and λ5 mRNA obtained from IgL repressible mice fed or not 
fed doxycycline, as indicated.  Pax-5 expression marks B cell lineage, whereas the absence of both Vpre-B and 
λ5 expression rules out pre-B cells.  PCR was done with 1:1, 1:5 and 1:25 cDNA dilutions. 
 
To confirm that the transgenic VH17.2.25 chain reaches the cell surface in the absence of IgL 
chains, we transfected SL and L chain-negative Ag8.653 first with a gene encoding Igα and 
then with a vector encoding the μH chain (VH17.2.25-μHC) identical to the one expressed in 
the IgL-repressible mouse (Figure 2D).  Figure 2E shows that the VH17.2.25-HC is 
transported to the surface of cells in the absence of LC.   
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FIGURE 2D:  Analysis of µHC expression in Ag8.H clones by Western Blot.  Ag8.H cell lines where 
transfected with a construct expressing Ig and another construct expressing the μHC VH17.2.25, the HC in the 
repressible IgL mouse that pairs with Igα.  The mature B cell line NYC served as positive control. 
 
FIGURE 2E:  Flow cytometry analysis of μHC VH17.2.25 surface and cytoplasmic expression in Ag8.H clones.  
Intracellular and membrane expression of Igα, and µHC in Ag8.H clones.  Untransfected Ag8.H-Igα served as 
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negative staining control (non-filled line).  Left column: Stable Ag8.H transfectants were cytoplasmic stained 
with 24C2.5 antibodies against the intracellular tail of mouse Igα, FITC-conjugated antibodies against mouse Fc 
served as secondary antibodies (grey-filled line).  Right column: Stable Ag8.H transfectants producing 
VH17.2.25 µHC were cytoplasmic or membrane stained with Cy5-conjugated antibodies against mouse µHC 
(grey histograms).  Figure shows that μHC VH17.2.25 is expressed on the surface.  Results shown are 
representative of three independent experiments. 
 
Surface LC-negative B cells are long lived 
The survival of pre-B cells and the survival of mature B cells is thought to depend on 
expression of a surface receptor (Lam et al., 1997; Reichlin et al., 2001).  Lam and colleagues 
(Lam et al., 1997) and Kraus and colleagues  found that repression of HC abolishes the 
expression of a complete BCR and causes death of B cells.  Whether B cells die because of the 
absence of surface BCR or to the absence of HC on its own was not determined.  In contrast, 
repression of LC in the IgL-repressible mouse abolishes the assembly of a complete BCR but 
does not affect surface HC expression.  To determine how long LC-negative B cells 
expressing neither BCR nor pre-BCR survive, we enumerated B cells in the spleen and in the 
peripheral blood of mice at different times following LC repression. The number of B cells in 
the spleen decreased 5-6 fold (from 2.4 to 0.4 million) four weeks after LC repression but it 
remained constant thereafter.  The decrease in the number of B cells in the spleen was not 
observed in the peripheral blood.  Figure 3A shows that the number of CD19-positive B cells 
in the blood remained constant for up to 14 weeks after the start of the DOX treatment.  Long-
lived B cells expressed bcl-6, blimp-1, activation induced cytidine deaminase (aid) and did not 
express c-myc mRNAs consistent with a non-cycling, post-germinal center phenotype (Figure 
3B).  Expression of aid and blimp-1 suggests the possibility that these factors are needed to 
establish or maintain survival of B cells in a non-terminally differentiated state. 
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FIGURE 3A:  CD19-positive B cells survive up to 14 weeks following the start of doxycycline treatment and 
repression of  LC as their number remains constant in the peripheral blood of IgL repressible mice.  Cells were 
enumerated by coulter counting and flow cytometry analysis of peripheral blood lymphocytes with rat 
monoclonal antibody anti-mouse CD19 APC-labeled.  Figure shows the average number of CD19-positive B 
cells obtained from 6 different mice treated with doxycycline and one untreated mouse analyzed at each time 
point. 
 
FIGURE 3B:  RT-PCR analysis of mRNA obtained from CD19-positive B cells isolated by MACS purification 
from pooled spleens of 6 repressible IgL mice fed or not fed doxycycline for 2 weeks.  Surviving B cells express 
bcl-6, blimp-1, activation induced cytidine deaminase (aid) and do not express c-myc mRNAs consistent with a 
non-cycling, post-germinal center phenotype. To control for DNA contamination of RNA samples, non-reverse 
transcribed C57BL/6 mRNA was PCR amplified (lane “-“). 
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Several factors could contribute to the maintenance of peripheral CD19-positive surface LC-
negative cells: de novo production of B cells, or proliferation in equilibrium with cell death 
and/or long life.  To determine whether repression of LC completely eliminates de novo 
production of B cells in the bone marrow, IgL-repressible mice were treated with doxycycline 
for two generations (to exclude transfer of maternal B cells to the fetus), after which B cells in 
the periphery were sought.  Flow cytometry analysis of splenocytes of IgL-repressible mice 
treated in this way revealed no B cells in the periphery (Figure 3C, right panel).  This result 
indicates that B cells are not produced de novo when production of lambda is repressed.  
 
FIGURE 3C:   LC repression abrogates de novo B cell production in the bone marrow of repressible Ig mice.  
Flow cytometry analysis of splenocytes obtained from IgL repressible mice generated and maintained with (right) 
or without (left) doxycycline for 2 generations.  Splenocytes were stained with rat anti-mouse monoclonal 
antibodies directed to CD19 or to  λ1, λ2 and λ3. 
 
It is possible that B cells surviving repression of LC are the progeny of rare B cells that 
proliferated to maintain the B cell compartment.  To test this idea we analyzed spleen sections 
co-stained with anti-Ki67 (a cell division marker).  Figure 3D shows that no µHC-positive 
cells express Ki67, and hence CD19-positive B cells were not proliferating to any great extent 
following repression of LC.  Consistent with this concept, tunnel analysis shows that 
splenocytes of mice treated with doxycycline for 4 weeks were not undergoing apoptosis (as 
might be expected in rapidly proliferating populations of cells) (Figure 3E).  These results 
show that repression of LC expression did not cause enhanced turnover of B cells, and 
therefore the maintenance of surface LC–negative B cells must be owed to long life. 
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FIGURE 3D:  Spleen sections of IgL repressible mice fed (right) or not fed (left) doxycycline and B6 controls 
were co-stained with anti-Ki67 (FITC-conjugated) and anti-IgM (H+L) antibodies (Rhodamine-conjugated), as 
noted (100X).  Surface Ig-negative B cells do not stain with anti-Ki67 antibody and thus are not dividing. 
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FIGURE 3E:  Spleen sections of IgL repressible mice fed (right) or not fed (left) doxycycline as well as B6 
controls were co-stained with tunnel antibody (Rhodamine-conjugated) and anti-CD19 antibody (FITC-conjugate 
d), as noted (100X).  1LC-negative B cells are TUNEL-negative and thus not undergoing apoptosis.  Results 
shown are representative of three independent experiments. 
 
HC expressed on the surface of cells is full length and signals 
Our results indicate that surviving surface LC-negative B cells continue to produce µHC and 
suggest the possibility that µHC expression in the absence of LC functions as a receptor.  
Because unpaired full-length µHCs are thought to be retained in the ER (Mielenz et al., 2003), 
we asked whether µHC expressed on the surface was full length.  Western Blot analysis of 
cellular and surface μHC separated by SDS-PAGE shows that LC-negative B cells expressed 
predominantly the full-length µHC on the surface (Figure 4A lane 5).  In addition to the full 
length protein, splenocytes from repressible IgL mice also produced a lower molecular mass 
band, visible in lanes 3 through 6 of figure 4A, migrating with an approximate molecular mass 
+DOX-DOX B6
CD19
Tunnel
Merge
 89 
of about 50 kDa.  The 50 kDa molecular mass band could correspond to IgG or alternatively a 
truncated HC, as has been described in some B cell malignancies (Witzig and Wahner-
Roedler, 2002).  Figure 4B shows that the 50 kDa MW bands are not IgG because they fail to 
be detected with an antibody directed against IgG. 
 
FIGURE 4A:  Western Blot analysis of surface and cytoplasm μHC in IgL repressible mice fed (right) or not fed 
(left) doxycycline as well as B6 controls.  Protein lysates obtained from isolated B cells were surface biotinilated 
and immuno-precipitated (with streptavidin beads).  Biotinilated samples (surface) and non biotinilated samples 
(cytoplasm) were analyzed by 10% SDS PAGE and blotted with goat anti-mouse IgM (H+L) antibody.  Figure 
shows that the full length μHC is expressed on the surface of LC-negative B cells.  Approximate molecular mass 
(MW) is noted on the right. 
 
FIGURE 4B:  Western Blot analysis of IgG and IgM in IgL repressible mice fed (right) or not fed (left) 
doxycycline as well as B6 controls.  Samples were analyzed by 10% SDS PAGE and blotted .  Blotted proteins 
were revealed with a goat anti-mouse IgM (H+L) or antimouse IgG antibodies as indicated.  Western Blot shows 
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that 50KD MW bands detected by the anti-IgM (H+L) antibody are not IgG because they fail to be detected with 
an antibody directed against IgG.  Approximate molecular mass (MW) is noted on the right. 
 
To determine whether the 50kDa band resulted from a truncated heavy-chain, lacking CH1 or 
the VH exon, we analyzed HC gene expression by RT-PCR.  Figure 4C shows that repressible 
Ig splenocytes express only the full-length RNA with no evidence of deletions in the variable 
or constant region exons (Figure 4C) indicating that the 50 kDa molecular mass band apparent 
in lanes 3-6 of figure 4A, is likely a degradation product.  The decrease in LC-repressed 
splenocytes µHC mRNA, apparent in figure 4C, is owed to the fact that LC-repressed mice 
have 5-fold to 6-fold fewer B cells compared to LC-expressing mice.  Our results indicate the 
possibility that limited light chain availability renders the monoclonal VH17.2.25 µHC more 
susceptible to proteolysis compared to the polyclonal µHC population in B6. 
 
FIGURE 4C:  RT-PCR analysis of the length of the HC mRNA obtained from splenocytes of IgL repressible 
mice fed or not fed doxycycline, as indicated.  Figure shows that the mRNA is full length, i.e., it does not contain 
deletions in the V or C exons.  Below is shown a schematic representation of the RT-PCR primers sites respective 
to HC mRNA.  1:1, 1:5 and 1:25 dilutions of the cDNA were used. 
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The surface expression of unpaired μHC suggested the possibility that HC alone delivers B 
cell survival signals.  To answer this question, we compared changes in the level of 
intracellular free Ca
2+
 in B cells stimulated with anti-IgM, whole antibody or F(ab)2.  Naïve 
QM B cells and surface LC-positive B cells from repressible IgL mice responded to IgM 
cross-linking by quickly increasing the intracellular Ca
2+
 (Figure 4D, upper and medium 
panel, blue line).  Changes in the level of intracellular free Ca
2+
 in QM or surface LC-positive 
B cells stimulated with anti-IgM had similar kinetics as those following stimulation with anti-
Igλ LC (green lines).  In contrast, surface LC-negative B cells responded to IgM cross-linking 
with a modest increase in the intracellular Ca
2+
 originating a lower amplitude and somewhat 
retarded peak when compared to λLC-positive B cells or QM B cells (Figure 4D, lower panel, 
blue line).  The amplitude of the Ca
2+
 peak in response to IgM cross-linking on the surface 
LC-negative B cells was reduced relative to wild type B cells, possibly owing to decreased 
surface receptor density.  Cross-linking Ig-L on surface LC-negative B cells originated no 
response (Figure 4D, lower panel, green line).  These results indicate that unpaired μHC 
generates signals.  
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FIGURE 4D:  Flow cytometry analysis of Ca
2+
 influx in isolated B cells, obtained from the spleen of QM, or 
from IgL-repressible mice fed or not fed doxycycline for four weeks.  Histograms represent the ratio of 
violet/blue fluorescence intensities (Indo1 bound to Ca
2+
/unbound Indo1) over time.  The cells were stimulated 
with either goat anti-mouse IgM (H+L) antibody (blue), with goat anti-mouse lambda antibody (green) or with 
control antibodies, goat IgG (red) added at 2 minutes after the start (indicated by the arrow).  Cross-linking of 
surface HC but not LC causes a modest Ca2+ influx by LC-negative B cells (lower panel).  Results are 
representative of four independent experiments. 
 
Unpaired HC in the cytoplasm triggers receptor-independent responses 
Because in the absence of LC, HC is retained in the endoplasmic reticulum (ER) by BiP 
(immunoglobulin HC binding protein) (Vanhove et al., 2001) we investigated whether LC-
negative B cells activated a stress response called the unfolded protein response (UPR).  We 
tested activation of several UPR transducers.  Activated inositol requiring enzyme 
endoribonuclease (IRE) (Wu and Kaufman, 2006) excises 26 base pairs from the X-box-
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binding protein 1 (XBP-1) mRNA to form XBP-1 spliced (s).  Activation of activating 
transcription factor 6 (ATF6), another UPR transducer, induces the transcription of xbp-1 and 
ER chaperone genes; eukaryotic translation initiation factor a, subunit α kinase (PERK) 
activation transiently inhibits cap-dependent protein synthesis and induces C (EBP) 
homologous protein (Chop).  Figure 5 shows that LC-negative B cells express the spliced (s) 
and unspliced (u) xbp-1 messages and have increased levels of BiP mRNAs consistent with 
inositol requiring enzyme 1α and activating transcription factor 6 activation.  Chop expression 
is consistent with PERK activation. These results indicate activation of all three UPR 
transducers and suggest the possibility that the UPR may contribute to the λLC-negative B 
cells’ long life.  
 
FIGURE 5: RT-PCR analysis of UPR genes.  mRNA obtained from CD19-positive B cells isolated by MACS 
purification from pooled spleens of 6 repressible IgL mice fed or not fed doxycycline for 2 weeks.  mRNA from 
adult C57BL/6 was used as a positive control.  To control for DNA contamination of RNA samples, non-reverse 
transcribed C57BL/6 mRNA was PCR amplified (lane -). 
 
We also tested whether several unfolded protein response gene mRNAs were produced in SL 
and L chain-negative, Igα-positive Ag8.653 expressing or not the transgenic VH17.2.25 chain.  
Our results (not shown), indicate that ire1, xbp-1, spliced and unspliced, chop, and edem1 
were equally expressed independently of the transgenic VH17.2.25 chain.  These results 
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indicate that in transformed cells activation of the UPR occurs independently of heavy chain 
expression.  These results do not contradict the possibility that accumulation of HC in the ER 
triggers the unfolded protein response in mature B cells independently of BCR stimulation. 
 
 95 
Discussion 
 
The property of memory that uniquely distinguishes adaptive immunity in host defense 
requires long-term survival of B cells after first exposure to antigen.  How long-term survival 
is achieved is not completely understood but thought to depend on surface expression of the 
antigen receptors.  Thus, survival of T cells depends on engagement of the TCR with self-
MHC plus self-peptide, assuring that only functional T cells live (Anderson et al., 1999).  In 
contrast to T cells, B cells recognize novel structures that are cleared from the organism.  
Thus, survival of mature B cells is thought to require a mature BCR (Kraus et al., 2004; 
Kurosaki, 2002; Lam et al., 1997), even though the necessity of a generic self-ligand has not 
yet been resolved.   
 
As one possibility, BCR may promote B cell survival by signaling constitutively.  This idea is 
supported by the work of Lam et al. (Lam et al., 1997) and Kraus et al. (Kraus et al., 2004), 
who showed that ablation of HC or Igα signaling in mature B cells led to rapid cell death (in 
days).  However, survival of B cells without BCR is not without precedent since BCR-less B 
cells expressing an Epstein Barr virus receptor instead of BCR survive in vitro and in vivo 
(Casola et al., 2004).  Because Epstein Barr receptor expressing B cells appear to activate Tyr-
phosphorylation of BCR targets, Casola and collaborators propose that BCR signaling is 
necessary for the survival of B cells (Casola et al., 2004).   
 
Here we report that survival of mature B cells does not require the complete BCR but rather 
the mere production of unpaired HC suffices to assure B cell survival.  In LC-negative B cells, 
µHC can be expressed on the surface.  Since surface μHC cross-linking induces a modest 
calcium influx we concluded that μHC can signal.  Signaling by unpaired surface μHC may be 
one mechanism promoting mature B cell survival.  Our results showing long-term survival of 
B cells expressing HC unpaired with LC support the concept that a B cell autonomous 
mechanism governs B cell longevity in the absence of a complete BCR.  
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Functional antibodies lacking light chains are produced by B cells in camels (Muyldermans 
and Lauwereys, 1999), nurse shark and wobbegong shark (Greenberg et al., 1995) and in 
ratfish (Rast et al., 1998) indicating that in these species B cells develop and persist in the 
absence of a conventional BCR.  Moreover, expression of dromedary HC-only antibodies in 
the mouse sustains B cell development (Janssens et al., 2006; Zou et al., 2005). 
 
HC-only antibodies in camels possess molecular adaptations, such as the loss of CH1 domain, 
to avoid interaction with light chains and binding to the heavy chain binding protein (BiP) thus 
escaping retention in the ER (Conrath et al., 2003; Knarr et al., 1995).  Truncated heavy chains 
have also been associated with disease in mice and in humans causing myeloma (Brandt et al., 
1984) or heavy chain disease (Corcos et al., 1995; Corcos et al., 1991; Fermand and Brouet, 
1999), respectively.  Heavy-chain disease–associated µ proteins lacking the rearranged VDJ 
exon (ΔµHC) produce unpaired HC receptors that are signaling competent.  Corcos et al. 
found that expression of ΔµHC promotes B cell differentiation in the bone marrow (Corcos et 
al., 1995; Corcos et al., 1991) and in the periphery.  However, mature B cells expressing 
ΔµHC are larger and have shorter half-lives than wild type B cells (Corcos et al., 2001).  This 
is in spite of the fact that ΔµHCs overcome BiP-mediated ER retention and are expressed on 
the surface (Corcos et al., 2001).  Since the HC produced by the IgL-repressible mouse is not 
truncated, our results indicate that when the availability of light chain is limited, full-length 
heavy chains may escape ER trapping and form signaling competent receptors.  Those may be 
important to promote survival of cells that loose LC expression owing to somatic 
hypermutation or receptor editing.   
 
That unpaired full-length μHC mediates some of the BCR functions was determined by Schuh 
et al. and Galler et al. (Galler et al., 2004; Schuh et al., 2003) who found that wild type full-
length μHC unbound to LC is expressed on the surface, promotes in vivo differentiation of 
pro-B cells , induces IL-7-dependent growth  and signals, causing decreased recombination 
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activating gene expression and allelic exclusion at the HC locus .  It is possible that expression 
of unpaired full-length HC contributes to the survival of human B cells lacking the 
conventional BCR in normal subjects (Pollok et al., 1987).  Expression of unpaired full-length 
HC may also contribute to the development of B cell malignancies by increasing the 
probability of survival of cells undergoing illegitimate DNA recombination or extensive DNA 
breaks.   
 
Expression of a BCR that is signaling competent does not by itself assure long life since 
immature B cells that are recent bone marrow emigrants have a very short lifespan (days) 
(Gaudin et al., 2004).  Thus, other mechanisms in addition to receptor-generated signaling are 
necessary.  Our results showing expression of unpaired μHC in the cytoplasm of LC-negative 
B cells suggest the possibility that cytoplasmic μHC contributes to the survival of mature B 
cells.  Perhaps the HC-only cells that survive repression of LC do so because of persistent 
unfolded protein response (UPR) initiated prior to repression of LC and accumulation of HC 
in the ER as described following cytokine and LPS stimulation of B cells (Gass et al., 2002; 
Skalet et al., 2005).  However, in contrast to LPS-activated blasts, HC-only cells do generate 
long lived B cells, suggesting that accumulation of HC in the ER may govern cell survival in 
addition to inducing terminal differentiation.  
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Abstract 
 
Activation-induced cytidine deaminase (AID) is required for immunoglobulin (Ig) class switch 
recombination, a process that introduces DNA double strand breaks in B cells.  We show here 
that AID associates with DNA-PKcs promoting cell survival, presumably by resolving DNA 
double strand breaks.  Wild type cells expressing AID mutants that fail to associate with 
DNA-PKcs, or cells deficient in DNA-PKcs or 53BP1 expressing wild type AID, accumulate 
γH2AX foci, indicative of heightened DNA damage response.  Thus AID has two independent 
functions.  AID catalyzes cytidine deamination that originates DNA double strand breaks 
needed for recombination, and it promotes DNA damage response and cell survival.  Our 
results thus resolve the paradox of how B cells undergoing DNA cytidine deamination and 
recombination exhibit heightened survival and suggest a mechanism for hyper IgM type II 
syndrome associated with AID mutants deficient in DNA-PKcs binding.   
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Introduction 
 
Activation-induced cytidine deaminase (AID) promotes somatic hypermutation (SHM) and 
class switch recombination (CSR) of immunoglobulin genes (Durandy, 2003a).  AID cytidine 
deaminase activity was first proposed on the basis of its homology with the apoB m RNA 
editing catalytic polypeptide 1 (APOBEC-1) (Muramatsu et al., 1999).  The cytidine 
deaminase property of AID led to two distinct hypotheses to explain diversification of the 
immunoglobulin (Ig) genes.  The first, the RNA editing hypothesis, proposes that AID, like 
APOBEC-1, modifies unknown RNA precursors that in turn, originate endonucleases that 
cleave the DNA encoding the Ig genes.  The findings by Begum et al (Begum et al., 2004), 
showing that AID-dependent DNA cleavage in CSR requires de novo protein synthesis is in 
agreement with this hypothesis.  The second, the DNA deamination hypothesis, proposes that 
AID deaminates cytidine to uracil directly in the DNA encoding the Ig genes .  Compatible 
with the second hypothesis are the results of Petersen-Marth et al.  showing that expression of 
AID in Escherichia coli originates a mutator phenotype that yields nucleotide transitions at 
dC/dG and the findings of Dickerson et al. (Dickerson et al., 2003), Pham et al. (Pham et al., 
2003) and Chaudhuri et al. (Chaudhuri et al., 2003) showing that AID deaminates DNA 
substrates in vitro.   
 
How exactly AID introduces point mutations or executes class switch recombination is not yet 
understood, but it is generally thought that cytidine deamination of DNA or RNA somehow 
generates double strand breaks in Ig DNA (Celeste et al., 2002; Durandy, 2003a; Papavasiliou 
and Schatz, 2000; Petersen et al., 2001; Zhang, 2003).  Ordinarily, cells respond to DNA 
double strand breaks by undergoing cell cycle arrest to allow time for repair (Nyberg et al., 
2002) and respond to persistent damage by inducing apoptosis, presumably as a protection 
against illegitimate recombination (Pfeiffer et al., 2000).  However, B cells undergoing Ig 
class switch do not die, presumably because they efficiently repair DNA double strand breaks.  
While RAD54 RAD52 and RAD51 repair proteins are needed for AID induced Ig gene 
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conversion in chicken cell lines (Bezzubova et al., 1997b; Sale et al., 2001) whether AID 
directly recruits repair factors to the locales of cytidine deamination is not known.   
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Materials and Methods 
 
Generation of AID wild type and mutant constructs 
RNA was obtained from C57BL/6 mouse lymph nodes using Trizol™ reagent.  AID cDNA 
was produced by reverse transcription using oligo-dT primer and amplified by PCR using 
Turbo pfu polymerase (Stratagene) and primer set wu160/wu167.  Full-length AID cDNA was 
cloned in-frame into pUHD10S vector downstream of Flag tag sequences. AID deletion 
mutants were generated by PCR using Turbo pfu.  The primer sets used to generate the 
deletion mutants were: mutant F1: wu160/wu166; mutant F3: wu160/wu165; mutant F4: 
wu162/wu167; mutant F6: wu161/wu167; and mutant C: wu160/wu174.  We used 
QuickChange mutagenesis kit (Stratagene) to generate AID-DN and AID-R112H point 
mutation constructs with primer sets wu155/wu156 and wu157/wu158, respectively. PCR 
fragments were flanked by 5’ NheI and 3’ XbaI sites to allow subsequent cloning into the 
pUHD10S vector.  The Flag-tagged AID fragment (EcoRI/XbaI) was subcloned into the pCI 
expression vector (Promega) for transient expression and into the pCI-neo expression vector 
(Promega) for stable transfections.  For expression in 70Z/3 cells and in splenocytes, Flag-
AID or Flag-AID-C fragments were cloned into pIRES2GFP vector (BD clontech) upstream 
of IRES-EGFP sequence followed by subcloning of the Flag-AID-(or Flag-AID-C)-IRES2-
EGFP cassette into the pMSCV-puro retroviral vector (BD clontech).  To produce the GST-
AID fusion protein, the full-length AID cDNA was cloned in-frame into the pGEX4T1 vector 
(Amersham).  All sequences were verified by DNA sequencing.  
 
Cell culture, transfection and retroviral transduction 
Wild type mouse embryonic fibroblasts (MEF) were generated from C57BL/6 mouse embryos 
at 14.5 dpc and maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% FCS, 1.0 IU/ml of penicillin G and 0.5 IU/ml of streptomycin.  HeLa cells and 
HEK293 cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) and 
supplemented with 10% FCS, 1.0 IU/ml of penicillin G and 0.5 IU/ml of streptomycin.  DNA-
PKcs
-/-
 MEF cells (PK33N) (Araki et al., 1999) were kindly provided by Dr. David J. Chen 
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(Lawrence Berkeley National Laboratory) and maintained in alpha-MEM supplemented with 
10% FCS, 1.0 IU/ml of penicillin G and 0.5 IU/ml of streptomycin.  Mouse pre-B lines 70Z/3 
and 18.81 cells were maintained in RPMI 1640 medium supplemented with 10% FCS, 1.0 
IU/ml of penicillin G and 0.5 IU/ml of streptomycin.  LPS cultures were prepared by 
incubating B cells (95% purity, isolated with a MACS column), 2x10
5
/well/100µl, with 
10µg/ml LPS (Sigma) in RPMI 1640 medium supplemented with 10% FCS, 1.0 IU/ml of 
penicillin G and 0.5 IU/ml of streptomycin.  B cells were obtained from C57BL/6 mice as 
described (Cascalho et al., 1996).   
 
Transient transfection of AID wild type or mutant construct into HeLa, HEK293 or MEF cells 
was performed with Lipofectamine (Invitrogen).  Expression of wild type AID in 70Z/3 cells 
and in splenocytes was done by retroviral transduction.  Linearized pMSCV- IRES2-EGFP-
Puro or pMSCV-Flag-AID-IRES2-EGFP-Puro DNA was stably transfected into RetroPack 
PT67 (BD Clontech) packaging cells by electroporation, whereas pMSCV-Flag-AID- -
IRES2-EGFP-Puro was transiently transfected into the same packaging line using 
lipofectomine. The virus-containing supernatant of each kind (in DMEM medium) was 
collected every 24 hours and further concentrated by centrifugation at 6000g for 4 hours. 
Virus pellets were resuspended in 1/50 volume of complete RPMI1640.  LPS cultures were 
transduced with proviruses at the time of seeding in 100 µl of virus-containing supernatant 
supplemented with 10 µg/ml of LPS.  AID and AID-C expressing splenocytes were analyzed 
with a FACScalibur (Becton Dickinson) by measuring GFP positivity and propidium iodide 
(PI) stain for cell death.  
 
Subcellular fractionation 
Nuclei and cytosol fractions were prepared according to published protocols (Kihlmark and 
Hallberg, 1998).  Briefly, 10
7
 HEK293 cells expressing Flag-AID were harvested and washed 
three times with PBS.  Cells were resuspended in 1 ml of lysis buffer [10 mM HEPES, pH7.5, 
10 mM KCl, 1.5 mM MgCl2, 1 mM DTT and protease inhibitor cocktail (Roche)] on ice for 
20 minutes followed by 20 gentle strokes for homogenization with a loose fit Dounce 
 113 
homogenizer.  The homogenate was overlaid on top of 200 ul of 40% sucrose in lysis buffer 
and centrifuged at 800g for 15 minutes in a centrifuge with swinging bucket rotor.  The 
supernatant (corresponding to the cytosolic fraction) and the pellet (corresponding to the 
nuclear fraction) were collected and extracted with 10 lysis buffer (Wu et al., 2003).  
 
Immunoprecipitation and Western Blotting 
Immunoprecipitation was performed as described previously (Wu et al., 2003).  To identify 
AID-binding proteins, 2x108 HeLa cells expressing Flag-AID were used for a large-scale 
immunoprecipitation with EZview anti-Flag (M2) beads (Sigma).  Otherwise, routine 
immunoprecipitation was carried out by using 2x107 cells expressing Flag-AID.  In each 
experiment, one-fourth of the precipitated proteins (equivalent to 5x106 cells) were resolved 
on a 6% SDS-PAGE (for DNA-PKcs and Ku80) or 12% SDS-PAGE (for AID).  In the 
experiments testing DNA dependence of AID/DNA-PKcs binding, one-fourth of precipitated 
beads were incubated with 100 µl of PBS alone or 10 mM of STDDP in PBS for 2 hours on 
ice to crosslink protein complexes. After quenching crosslinking reaction with 10 µl of 1.0 M 
Tris-HCl, pH7.4 for 15 minutes and washed twice with PBS, the beads were then treated with 
20 units of DNase-I (as indicated in Figure 3B) in a 40 µl of PBS at room temperature for 30 
minutes, followed by 2 washes prior to SDS-PAGE analysis under reducing condition (5% -
mercaptoethanol) to cleave crosslinked complexes.  Mouse monoclonal anti-Flag (M2) 
antibody was purchased from Sigma.  Rabbit anti-DNA-PKcs (specific for human DNA-PKcs, 
SC-9051), monoclonal anti-Ku80 (SC-5280) were purchased from Santa Cruz.  Monoclonal 
anti-DNA-PKcs (specific for mouse DNA-PKcs; NA57) was obtained from Oncogene, goat 
anti-GST antibody is a product of Amersham (27-4577-01), monoclonal anti- tubulin was 
obtained from Santa Cruz Biotechnology, Inc. (SC-5274) and rabbit anti-AID serum was a 
generous gift from Dr. Frederick W. Alt (Harvard Medical School).   
 
DNA-PKcs in vitro pulldown by GST-AID 
Recombinant GST and GST-AID fusion protein were purified from bacterial DL21 cells.  500 
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ng of GST or GST-AID fusion protein beads were incubated with 0.5 ml cell extracts obtained 
from 2107 HEK293 cells overnight at 4C, in the presence or absence of 2 g of single 
stranded (ss) DNA, 2 g of double stranded (ds) DNA, or 20 units of DNase-I.  ssDNA was a 
59-base oligonucleotide containing RGYW repeats (AGCTGGCAGGCTAGCAAGTTGGTT-
GGCAAGCAGGTAAGCAGG CAAGCTGGCTGAATTCC) (Chaudhuri et al., 2003).  
dsDNA was an EcoRV linearized pBluescript KS vector (Stratagene).  Beads were washed 
and analyzed as described above.   
 
Immunofluorescence staining and microscopy 
Immunofluorescence staining and confocal microscopy were performed essentially as 
described previously (Wu et al., 2003).  For microtubule staining in HeLa cells expressing 
Flag-AID, cells were fixed with methanol at -20
º
C for 10 minutes, air dried, rehydrated, 
repermeabilized with 0.05% Triton X-100 in PBS for 3 minutes and blocked for 90 minutes 
with blocking buffer (5% normal goat serum, 1% glycerol, 0.1% BSA, 0.1% fish skin gelatin, 
0.04% sodium azide) followed by staining with anti- tubulin antibody (Sigma, T5293). 
Cytoplasmic protein extraction was done by incubating HeLa cells expressing GFP or Flag-
AID with 50 g/ml of digitonin in PBS on ice for 5 minutes followed by 4 washes with PBS 
and fixation with 4% paraformaldehyde. Affinity purified rabbit anti-H2AX were kindly 
provided by Dr. Junjie Chen (Mayo Clinic, Rochester, MN). Cell death of mouse embryonic 
fibroblasts was determined
 
by TUNEL assay (Promega) and by the presence of condensed 
chromatin
 
or fragmented nuclei in DAPI staining (Shimodaira et al., 2003). 
 
Identification of AID-associated proteins 
The proteins co-immunoprecipitated with Flag-AID from HeLa cells were resolved on a SDS-
polyacrylamide gel electrophoresis (PAGE) (4 to 15% polyacrylamide gradient) (Bio-Rad) 
and stained with Coomassie G-250 (Bio-Red). Protein bands were excised and analyzed using 
Matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry 
by the Rockefeller University Protein Resource Center (New York, NY).  
 115 
 
Oligonucleotides used 
Wu155:CTTCGCAACAAGTCTGGCTGCCGCGTGCAATTGTTGTTCCTACGCTACATC 
Wu156: 
GATGTAGCGTAGGAACAACAATTGCACGCGGCAGCCAGACTTGTTGCGAAG  
Wu157: CAGCCTGAGGATTTTCACCGCGCACCTCTACTTCTGTGAAGACCGC  
Wu158: GCGGTCTTCACAGAAGTAGAGGTGCGCGGTGAAAATCCTCAGGCT 
Wu160: GAATCAGCTAGCGACAGCCTTCTGATGAAGCAAAAG 
Wu161: GAATCAGCTAGCGGCTGCCACGTGGAATTGTTGTTC 
Wu162: GAATCAGCTAGCGAGGGGCTGCGGAGACTGCACC 
Wu165: GAATCATCTAGATTAAGGCTCAGCCTTGCGGTCTTCAC 
Wu166: GAATCATCTAGATTAATTTTCTACAAATGTATTCCAGCAG 
Wu167: GAATCATCTAGATTAAAATCCCAACATACGAAATGCATC 
Wu174: GAATCATCTAGATTAGTCATCGACTTCGTACAAGGGCAAAAGG 
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Results 
 
AID binds to DNA-PKcs in the nucleus 
We considered the possibility that association of AID with cofactors could promote survival of 
cells undergoing immunoglobulin gene diversification.  To determine whether AID associates 
with other molecules, we analyzed AID protein complexes obtained from HeLa cells 
expressing AID.  AID was immunoprecipitated from lysates, and the identity of any co-
precipitates was sought by mass spectrometry.  Figure 1A shows a Coomassie-stained gel 
image showing proteins co-immunoprecipitated with AID.  Matrix-assisted laser desorption 
ionization time-of-flight (MALDI-TOF) mass spectrometry identified the largest co-
precipitated protein as DNA-PKcs with a molecular weight of 486 kDa based on 34 matched 
peptides.  Other proteins identified were heat shock 70kDa protein 8 isoform 1 (HSC70) (12 
matched peptides), tubulin beta 2 (15 matched peptides) and a protein similar to mitochondrial 
solute carrier family 25 (4 matched peptides) (Figure 1). 
 
FIGURE 1:  Identification of AID binding proteins.  Comassie Blue staining of 4-15% gradient SDS-PAGE 
analysis of anti-Flag immunoprecipitates of lysates obtained from HeLa cells transiently transfected with Flag-
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AID or empty vector (mock).  Flag-AID co-migrates with the antibody light chain (25KD).  AID binding proteins 
were identified by MALTI-TOF mass spectrometry.  Protein identities and accession numbers are indicated.   
 
Since DNA-PKcs is required to efficiently resolve by non-homologous end-joining the DNA 
double strand breaks associated with class switch recombination (Manis et al., 2002), we 
questioned whether AID associated with DNA-PKcs in B lineage cells and cells other than 
HeLa.  Figure 2A shows DNA-PKcs co-immunoprecipitated with AID and vice versa, in 
extracts from HeLa cells, human embryonic kidney 293 (HEK293) cells, and murine B cells 
(70Z/3) transfected with Flag tagged AID.  We further show in Figure 2B that endogenously 
expressed AID in 18.81 B cells (Bachl et al., 2001) binds to DNA-PKcs (right panel).  Our 
results indicate that the association of AID with DNA-PKcs may reflect the function of AID in 
B cells.   
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FIGURE 2:  AID associates with DNA-PKcs of B and non-B cells.  (A)  AID co-precipitates with DNA-PKcs in 
various AID transfected cell lines.  Shown are western blot (WB) analysis of anti-Flag or anti-DNA-PKcs 
immunoprecipitates (IP) of cell lysates obtained from HeLa, HEK293 or 70Z/3 cells transfected with Flag-AID 
(+) or empty vector (-).  Blots were probed with either anti-Flag (Flag) or anti-DNA-PKcs (DNA-PKcs) 
antibodies, as indicated.  Mouse Ig light chain co-migrating with 25 kD Flag-AID, is seen as a weak band in the 
controls.  Figure is representative of 3 independent experiments.  (B)  Endogenous AID associates with DNA-
PKcs.  Shown is a western blot (WB) analysis (left panel) of anti-DNA-PKcs immunoprecipitates (IP) of cell 
lysates from mouse pre-B cell line 18.81 that constitutively expresses AID or from mouse pre-B cell line 70Z/3 
that does not express endogenous AID. Blots were probed with either anti-DNA-PKcs antibodies or rabbit 
polyclonal anti-AID (Chaudhuri et al., 2003) as indicated.  Expression of endogenous AID in 18.81 and 70Z lines 
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was verified by RT-PCR as shown in the right panel.  (C)  AID and DNA-PKcs associate in the nucleus.  Shown 
is a western blot analysis of Flag-AID or DNA-PKcs immunoprecipitates from whole cell extracts, cytoplasmic 
fraction, or nuclear fraction obtained from HEK293 cells expressing AID.  The blots were probed with either 
anti-DNA-PKcs or anti-Flag antibodies, as indicated.   
 
AID is mainly localized to the cytoplasm (Rada et al., 2002), whereas DNA-PKcs localizes 
predominantly in the nucleus (Koike et al., 1999), and yet they associate with one another.  
We asked whether the association of DNA-PKcs and AID took place in the nucleus where 
presumably AID and DNA-PKcs function.  Figure 2C shows that DNA-PKcs co-precipitates 
with AID in the nuclear fraction but not in the cytoplasmic fraction of cell extracts (Figure 
2C).  Our results indicate that the association of DNA-PKcs and AID takes place in the 
nucleus, representing the small fraction of total cellular AID (Figure 2C).  
 
Association of AID and DNA-PKcs requires the C-terminal and deamination 
domains of AID 
Because DNA-PKcs is required for the repair of DNA double strand breaks during class 
switch recombination (Manis et al., 2002) but is dispensable for somatic hypermutation 
(Bemark et al., 2000), our findings showing that AID associates with DNA-PKcs predict that 
the complexes mediating class switch recombination and somatic hypermutation are distinct.  
Recent findings from two laboratories support this idea (Barreto et al., 2003; Ta et al., 2003).  
Barreto et al. (Barreto et al., 2003) found that an AID mutant that lacks the C-terminal 10 
amino acids retained cytidine deaminase activity but failed to promote class switch 
recombination.  Ta et al. (Ta et al., 2003) found that some subjects with type II hyper-IgM 
syndrome have mutations in AID causing truncation or disruption of the C-terminal domain.  
These individuals have a severe defect in class switch but normal somatic hypermutation (Ta 
et al., 2003).  These findings suggested that the C-terminal region of AID is necessary for 
class switch recombination in B cells (Barreto et al., 2003; Ta et al., 2003).   
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We questioned whether the selective defect in class switch recombination of AID C-terminus 
deletion mutants reflected defective association with DNA-PKcs.  To test this idea, we 
generated a series of AID deletion mutants and tested the mutants for association with DNA-
PKcs.  C-terminal truncation mutants lost [mutant F1 (positions 1-154) and C (positions 1-
189)] or markedly reduced [mutant F3 (positions 1-123)] their ability to bind to DNA-PKcs 
(Figures 3A and 3B), suggesting that the C-terminal domain of AID is necessary for the 
formation of AID/DNA-PKcs complexes.  On the other hand, mutant F6 (positions 54-198) 
lacking the N-terminal 53 amino acid segment of AID retained the ability to bind to DNA-
PKcs.  However, mutant F4 (positions 124-198) with a larger deletion encompassing the 
deamination domain did not bind to DNA-PKcs (Figures 3A and 3B).  These results led us to 
speculate that the binding of AID to DNA-PKcs also requires the deamination domain.   
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FIGURE 3:  AID deamination and C-terminal domains are required for binding to DNA-PKcs.  (A)  Schematic 
domain representation of full-length AID and deletion mutants.  DNA-PKcs binding of wild type or deletion 
mutants is noted on the right. Wild type AID, Mutants F1 and F6 associate with DNA-PKcs; Mutants F1, F4 and 
C do not. (B)  Deamination and C-terminal domains of AID are necessary for binding to DNA-PKcs.   Shown is 
a western blot (WB) analysis of anti-Flag immunoprecipitates (IP) obtained from lysates of HEK293 cells 
transiently transfected with wild type (wt) or deletion mutants (F1, F3. F4, F6 and C) of AID.  Blots were 
probed with either anti-Flag or anti-DNA-PKcs antibodies, as indicated.  (C)  Cytidine deamination defective 
AID mutants do not bind to DNA-PKcs.  Shown is a western blot (WB) analysis of anti-Flag immunoprecipitates 
obtained from lysates of HEK293 cells stably expressing Flag tagged AID-wt, dominant negative H56R/E58Q 
mutant (DN), or R112H mutant AID.  Blots were probed with either anti-Flag or anti-DNA-PKcs antibody, as 
indicated.  The figures are representative of 3 independent experiments each.   
 
Deletion of the AID deamination domain could abrogate binding to DNA-PKcs because of 
alteration in the conformation of the AID C-terminus or because of inactivation of the cytidine 
deaminase activity.  To determine whether inactivation of cytidine deaminase activity 
abrogated binding to DNA-PKcs, we tested the ability of two deamination defective AID 
mutants to associate with DNA-PKcs.  An AID dominant negative mutant (AID-DN, 
H56R/E58Q) (Chaudhuri et al., 2003; Papavasiliou and Schatz, 2002) exhibited no binding, 
and an AID variant found in some patients with type II hyper-IgM syndrome (AID-R112H) 
(Revy et al., 2000; Ta et al., 2003) exhibited very little binding to DNA-PKcs (Figure 3C).  
These results show that subtle mutations in the deamination domain of AID that impair 
cytidine deaminase activity abrogate binding to DNA-PKcs.   
 
Association of AID and DNA-PKcs is DNA-dependent 
Some propose that AID promotes isotype class switch by deaminating cytidines in the DNA of 
switch regions (Reina-San-Martin et al., 2003), others that AID edits RNA originating a class 
switch specific factor such as an exonuclease or endonuclease to resect DNA ends (Doi et al., 
2003).  Since our results indicate that the AID deamination domain is necessary for the 
recruitment of DNA-PKcs, we asked whether DNA is a co-factor for AID and DNA-PKcs 
complex formation.  To answer this question, we tested whether a GST-AID fusion protein 
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associates with DNA-PKcs in the presence or in the absence of DNA.  Figure 4A shows that 
addition of exogenous single stranded (ss) DNA or double stranded (ds) DNA increases the 
efficiency of DNA-PKcs precipitation from HEK293 extracts by immobilized GST-AID 
(Figure 4A, lanes 3 and 4).  Precipitation reflected the specific properties of DNA since adding 
DNase-I disrupted GST-AID/DNA-PKcs complex formation (Figure 4A, lanes 5-7).  
Likewise, DNase-I treatment also caused dissociation of co-immunoprecipitated AID/DNA-
PKcs complexes (Figure 4B, left panel).  However, when the immunoprecipitates were 
crosslinked with primary amine-reactive and thiol-cleavable crosslinker 3, 3’-Dithiobis-
(sulfosuccinimidylpropionate) (STDDP) that only crosslinks proteins, DNase I treatment could 
no longer dissociate DNA-PKcs from AID (Figure 4B, right panel).  These results indicate that 
AID and DNA-PKcs form a stable complex through protein-protein interaction requiring DNA 
as a co-factor.   
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FIGURE 4:  AID associates directly with DNA-PKcs and association requires DNA as a co-factor.  (A)  DNA is 
a co-factor for DNA-PKcs binding to AID because the complex is dissociated by DNase I treatment (lanes 5, 6 
and 7) and enhanced by addition of double (lane 3) and single stranded DNA (lane 4).  Shown is a western blot 
(WB) analysis of GST or GST-AID bead pulldowns of HEK293 whole cell extracts in the presence or absence of 
single stranded (ss) or double stranded (ds) DNA and with or without of DNase-I.  Blots were probed with either 
anti-DNA-PKcs or anti-GST antibodies, as indicated.  (B) DNA-PKcs and AID associate via protein-protein 
interaction because cross linking abolishes sensitivity of the complex to DNAase I.  Shown is a western blot 
(WB) analysis of anti-Flag immunoprecipitates obtained from whole cell lysates of HEK293 cells expressing 
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Flag tagged wild type AID treated with or without a cross linker (DTSSP) and subsequently with or without 20 
units of DNase-I after immunoprecipitation.  Cross linking was disrupted with 𝛽-mercaptoethanol before SDS-
PAGE and western blot analysis.  Blots were probed with either anti-Flag or anti-DNA-PKcs antibodies, as 
indicated.  (C)  DNA-PKcs association with AID is independent of Ku80.  Shown is a western blot (WB) analysis 
of immunoprecipitated AID/DNA-PKcs complexes probed with anti-DNA-PKcs, anti-Flag or anti-Ku80 
antibody, as indicated.  To show the presence of the tested proteins and the antibody reactivity, we included total 
cell extract from AID expressing HEK293 cells (first lane in each panel) equivalent to 1% of material used in 
immunoprecipitation as positive control.  (D)  Sequence alignments of the C-terminal domains of mouse (m), 
human (h) AID and human (h)Ku80.   
 
It is generally thought that high affinity binding of DNA-PKcs to DNA breaks requires the 
association with Ku70/Ku80 heterodimer (West et al., 1998).  Hence, we asked whether Ku80 
was also present in AID/DNA-PKcs complexes.  Figure 4C shows that Ku80 is not detectable 
in the AID/DNA-PKcs complexes while it is clearly present in the cell extracts (Figure 4C, 
control lanes).  This result suggests that DNA-PKcs does not bind to Ku80 while it is 
associated with AID.  
 
AID C-terminal deletion mutant causes cell death 
How does the association of DNA-PKcs contribute to the function of AID?  DNA-PKcs is 
thought to contribute to the generation of lymphocyte receptors by promoting the repair of 
double strand breaks generated during V(D)J and class switch recombination by NHEJ (Gao et 
al., 1998).  Because persistent DNA double strand breaks cause cell death, repair mediated by 
DNA-PKcs may be critical for cell survival.  Consistent with this idea is the finding that mice 
deficient in DNA-PKcs lack B and T lymphocytes (Gao et al., 1998) and also exhibit 
hypersensitivity to agents that cause double strand breaks such as ionizing radiation (Gao et 
al., 1998).  Hence, we asked whether recruitment of DNA-PKcs by AID promotes survival of 
cells undergoing DNA breaks associated with cytidine deamination (Petersen et al., 2001).  To 
test this idea, we measured DNA damage foci and death of cells expressing the wild type or 
the C-terminal deletion mutant AID (AID-C).  Figure 5A shows that transient expression of 
AID-C that does not bind DNA-PKcs in mouse embryonic fibroblasts (MEF) resulted in 
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18% dead cells, while transient expression of wild type AID led to only 5% dead cells, which 
was comparable to the cell death observed in non-transfected cells (NT) (4.5%).  Our results 
indicate that recruitment of DNA-PKcs by AID promotes cell survival.   
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FIGURE 5:  Association of AID with DNA-PKcs protects cells from death and do not form nuclear H2AX foci.  
(A)  Expression of an AID C-terminal deletion mutant (AID-C) but not wild type AID (AID-wt) induces cell 
death.  Shown are representative confocal images (left panels) of wild type MEF cells transiently transfected with 
Flag tagged AID-wt or Flag tagged AID-C.  At 24 hour post-transfection, apoptosis of Flag positive cells (red) 
was scored for TUNEL positivity (green) and DAPI staining (blue).  The chart (right panel) shows the proportion 
of apoptotic cells 24 hours following transfection. Data was collected from 4 independent experiments by scoring 
at least 500 cells per experiment.  NT represents non-transfected cells.  (B) Expression of C-terminal deleted 
mutant AID (AID-C) but not wild type AID (AID-wt) induces the formation of nuclear H2AX foci. Shown are 
representative confocal images (left panels) of wild type MEF cells transiently transfected with Flag-AID-wt or 
Flag-AID-C, immunostained with anti-Flag (red), anti-γH2AX (green) antibodies and counterstained with DAPI 
(blue).  The chart (right panel) shows the proportion of nontransfected (left panel, white arrows) or transfected 
(red arrows) cells with large nuclear H2AX foci 24 hours following transfection.  Data was collected from 3 
independent experiments by scoring at least 150 cells per experiment.  (C)  Expression of wild type AID causes 
DNA damage foci in repair deficient cells.  Shown are representative confocal images (left panels) of DNA-PKcs
 
-/-
 or 53BP1
-/- 
MEF cells transiently transfected with Flag-AID-wt, immunostained with anti-Flag (red), anti-
H2AX (green) antibodies and counterstained with DAPI (blue). The chart (right panel) shows the proportion of 
nontransfected (left panels, white arrows) or transfected (red arrows) cells with large nuclear H2AX foci 24 
hours following transfection. Data was obtained from 3 independent experiments by scoring at least 150 cells per 
experiment.   
 
AID C-terminal deletion mutant causes heightened DNA damage response 
To test whether expression of AID-C led to DNA damage response, we stained MEF cells 
expressing wild type or AID-C proteins for phosphorylated H2A histone family member X 
(H2AX), which binds to DNA double strand breaks forming foci (Petersen et al., 2001).  
Figure 5B shows that only 1.1% of non-transfected MEF cells (Figure 5B, white arrows) and 
9.4% cells transfected with AID-wt (Figure 5B, white arrows) exhibited detectable nuclear 
H2AX foci.  In contrast, 75.6% MEF cells expressing AID-C had massive accumulation of 
nuclear H2AX foci (Figure 5B, red arrows).  Our data is consistent with the concept that 
recruitment of DNA-PKcs by AID is needed to resolve DNA double stranded breaks.   
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DNA-PKcs and 53BP1 are necessary to resolve AID-generated γH2AX foci 
Absence of H2AX nuclear foci in wild type MEF cells expressing wild type AID could result 
from prompt DNA repair or alternatively from decreased DNA break formation.  To determine 
the contribution of DNA repair to the lack of DNA damage foci in cells expressing wild type 
AID, we examined DNA damage foci in repair-deficient cells expressing wild type AID.  
Figure 5C shows that expression of wild type AID induced nuclear H2AX foci in 80.5% 
DNA-PKcs
-/-
 cells, while only 9.3% of non-transfected cells scored positive.  Similarly, 
expression of wild type AID also induced H2AX foci in 64% 53BP1-/- cells (Ward et al., 
2003) while only 17.2% non-transfected cells were positive.  These results indicate that AID 
generates DNA double strand breaks and γH2AX foci, which accumulate in the absence of 
DNA-PKcs or other DNA repair components such as 53BP1.  
 
AID C-terminal deletion mutant impairs survival of activated B cells  
Our results indicating that AID deficient in DNA-PKcs binding causes accumulation of DNA 
double strand breaks suggest a mechanism for the selective class switching defect in some 
patients with hyper IgM type II syndrome.  We tested whether expression of AID mutants 
deficient in DNA-PKcs binding owing to C-terminal deletion (AID-C) impaired survival of 
B cells undergoing class switch recombination.  To do this, we transduced lipopolysaccharide 
(LPS) activated B cells obtained from spleens of wild type C57BL/6 mice with retroviral 
vectors encoding wild type AID (AID-wt), or AID-C or GFP (Figure 6A).  Figure 6B shows 
that while 91.6% AID-C transduced B cells (GFP-positive) were dead at day 3 of LPS 
culture, only 25.2% of the cells transduced with AID-wt and 19.2% of the cells expressing 
only GFP died (Figure 6B).  Our results indicate that AID-C causes death of cells undergoing 
LPS stimulation.  We observed that the surviving AID-C expressing cells did not class 
switch, thus confirming the findings of Barreto et al. (Barreto et al., 2003) who showed that 
AID-C does not promote class switch.  Because AID-C transduced B cells undergo cell 
death, our results indicate that AID-C associated defective class switch is owed to the death 
of the cells undergoing class switch recombination. 
 129 
 
FIGURE 6:  AID C-terminal deletion mutant (AID-ΔC) induces cell death of LPS stimulated B cells.  (A). 
Schematic representation of the retroviral constructs used to transduce B cells. (B) C-terminal deleted mutant 
AID (AID-C) but not wild type AID (AID-wt) induces death of LPS stimulated B cells.  Cell death was scored 
by propidium iodide (PI) staining of LPS stimulated splenocytes transduced with proviruses encoding green 
fluorescent protein (GFP), wild type AID (AID-wt), or C-terminal deleted AID mutant (AID-C), at day 3.  PI 
positive cells were identified by flow cytometry analysis.  Graph represents the fraction of transduced B cells 
(GFP-positive) that were PI-positive (y-axis). Data was collected from 3 independent experiments and represents 
means and standard deviations.    
 
C-terminal deletion does not alter AID intracellular localization 
McBride et al. (McBride et al., 2004) and Ito et al. (Ito et al., 2004) proposed an alternative 
mechanism for the impaired class switch recombination by AID-C mutants.  These authors 
suggested that deficient class-switch is a consequence of deletion of a leucine rich nuclear 
export signal causing predominant nuclear localization of AID-C (Ito et al., 2004; McBride 
et al., 2004).  However, Figures 5A and 5B show that Flag-tagged AID-C like wild type 
AID, localized predominantly in the cytoplasm of mouse embryonic fibroblasts.  Our results 
showing that removal of the nuclear export signal (aa 189-198) in the Flag-tagged AID-ΔC did 
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not alter intracellular localization of the protein indicate that the pro-death effect of AID-ΔC is 
not due to nuclear accumulation.   
 
Intracellular localization of AID may not be primarily governed by nucleocytoplasmic 
shuttling.  If AID shuttled between cytoplasm and nucleus, then addition of nuclear 
localization signal should drive AID to the nucleus.  Figures 7A-E show that while addition of 
three consecutive copies of SV40 nuclear localization signals (Moore and Blobel, 1992) 
efficiently drives GFP in to the nucleus (Figure 7B), AID remains in the cytoplasm (Figure 
7E).  These results suggest the possibility that AID is actively retained in the cytoplasm.  
Consistent with this possibility, cytoplasmic localization of wild type AID is resistant to 
digitonin treatment (Figure 7F) that effectively depletes GFP from the cytoplasm of the cells 
(Figure 7C).  Our data indicates that AID is retained in the cytoplasm by digitonin-resistant 
cytoskeletal elements.  One of such elements is -tubulin because -tubulin specifically co-
precipitated (Figures 1 and 7G) and partially co-localized (Figures 7H-J) with AID. 
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FIGURE 7:  AID is retained in the cytoplasm by cytoskeletal proteins.  GFP distributes in the cytoplasm and in 
the nucleus of HeLa cells (A) while Flag-AID localizes predominantly to the cytoplasm.  Addition of three SV40 
nuclear localization signals to GFP (3xNLS-GFP) or to Flag-tagged AID (3xNLS-AID) causes nuclear 
localization of GFP (B) but not Flag-tagged AID (E).  Digitonin treatment of cells removes GFP (C) but not Flag-
tagged AID (F) from the cytoplasm indicating cytoplasmic retention of AID.  (G) AID associates with -tubulin.  
Shown are western blot (WB) analysis of anti-Flag immunoprecipitates (IP) of cell lysates obtained from HeLa, 
HEK293 or 70Z/3 cells transfected with Flag-AID (+) or empty vector (-).  Blots were probed with either anti-
Flag or anti- tubulin antibodies, as indicated.  Mouse Ig heavy chain migrating slight above  tubulin, is seen as 
a weak band in the controls.  (H-J)  AID partially colocalized with  tubulin.  Shown are confocal images of 
HeLa cells expressing Flag-AID double stained with Flag (red)and anti--tubulin (green) antibodies.  
Arrowheads show co-localization of AID and  tubulin. 
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It is possible that the properties of AID-GFP fusion proteins studied by McBride et al. 
(McBride et al., 2004) and by Ito et al. (Ito et al., 2004) differ from the properties of Flag-
tagged AID or of the native AID.  While the intracellular distribution of Flag-tagged AID-ΔC 
is determined by cytoplasmic retention, the distribution of AID-ΔC-GFP fusions is not.  
Instead, intracellular distribution of AID-ΔC-GFP fusion proteins is determined by nucleo-
cytoplasminic shuttling.   
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Discussion 
 
We show here that AID promotes cell survival by recruiting DNA-PKcs to the DNA, hence 
resolving double strand breaks.  Our findings explain how B cells survive while undergoing 
DNA double strand breaks during class switch recombination.  Consistent with this notion, 
compromised class switch recombination is a common phenotype in mice deficient in proteins 
that are necessary for DNA damage repair such as H2AX (Reina-San-Martin et al., 2003), 
ATM (Pan-Hammarstrom et al., 2003), 53BP1 (Manis et al., 2004) and Mre11 (Lahdesmaki et 
al., 2004).   
 
Gell and Jackson (Gell and Jackson, 1999) showed that DNA-PKcs associates with 
Ku70/Ku80 binding to the 12 amino acid C-terminal tail of the Ku80 subunit.  Our data show 
that DNA-PKcs binding to AID requires the C-terminus of AID (Figures 3A and 3B).  Such a 
striking binding parallel made us wonder whether the C-terminal domain of Ku80 might be 
homologous in any way to the C-terminal domain of AID.  Sequence alignment of the 14 
amino acid C-terminal domains of AID and Ku80 revealed that both sequences possess a 
common (E/D)VDDL(X)D motif (Figure 4D).  The common motif in the C-terminal domains 
of AID and Ku80 suggest competition for the same binding site on DNA-PKcs.  This 
mechanism may coordinate the formation of AID/DNA-PKcs and of Ku70/Ku80/DNA-PKcs 
complexes for repair of double strand breaks by non-homologous end joining (NHEJ) 
following cytidine deamination of DNA.   
 
We propose a working model to explain how AID promotes survival of cells undergoing DNA 
double strand breaks.  AID binding to DNA through the DNA deamination domain undergoes 
a conformational change resulting in the exposure of the C-terminal domain that, in turn, 
recruits DNA-PKcs to the DNA.  Upon the generation of DNA breaks by cytidine 
deamination, DNA-PKcs initiates NHEJ by dissociating from AID and re-associating with 
Ku80 to assemble the NHEJ repair complex.  Our results thus explain previous observations 
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by Barreto et al. (Barreto et al., 2003) and Ta et al. (Ta et al., 2003) who showed that C-
terminal deleted AID mutants fail to promote class switch recombination.  Our results suggest 
that the mechanism underlying hyper IgM type II syndrome associated with AID mutations 
that truncate the C-terminal portion of the molecule are owed to selective death of B cells 
stimulated to undergo class switch recombination because of accumulation of DNA double 
strand breaks.  That C-terminal deleted AID mutants may sustain somatic hypermutation (Ta 
et al., 2003) is also in agreement with our findings since somatic hypermutation is less 
dependent on the recruitment of DNA-PKcs than class switch recombination, possibly due to 
engagement of alternative repair mechanisms (Bardwell et al., 2004; Cascalho et al., 1998).  
Our results may also explain why lack of DNA-PKcs causes class switch deficiency for all 
isotypes except IgG1 (Manis et al., 2002), while the SCID mutation, which truncates DNA-
PKcs, allows moderate class switching to all isotypes (Bosma et al., 2002).  While AID in the 
absence of DNA-PKcs is unable to recruit repair factors to the sites of cytidine deamination, it 
may do so in the presence of DNA-PKcs with the SCID mutation. 
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Final discussion and conclusion 
 
This thesis originated from studies on the molecular mechanisms that contribute to B cell 
survival before and after activation in response to immunologic stimuli. We examined which 
BCR properties impart long life to B cells and asked if expression of unpaired 
immunoglobulin heavy chain promotes the survival of B cells. Next, we examined the 
molecular mechanisms of B cell survival in the presence of DNA double strand breaks during 
terminal differentiation, namely, the role of AID in DNA repair during terminal 
differentiation. 
 
To exist, B cells must express a functional receptor on the surface. How does the B cell 
receptor contribute survival signals to the cell is not known. The research related in this thesis 
examined the contribution of unpaired immunoglobulin heavy chain to the survival of B cells 
following repression of immunoglobulin light chain expression. We studied the fate of B cells 
in a murine model where expression of light chain can be conditionally repressed without 
impairing heavy chain production (Geraldes et al., 2007). We found that survival of mature B 
cells did not require a completed B cell receptor but rather the mere production of unpaired 
heavy chain sufficed to assure B cell survival. Immunoglobulin light chain-negative B cells 
expressed µHC on the surface and the µHC retained signalling competency since cross-linking 
induced calcium influx. Generally, expression of unpaired heavy chain on the surface of B 
cells requires overcoming aggregation in the endoplasmic reticulum, a function dependent on 
the second exon of the µ constant region and mediated by association with light chain or by 
loss of exon 2 as in some B cell malignancies(Fermand and Brouet, 1999). Since we found no 
heavy chain truncations our results indicate that when the availability of light chain is limited, 
full-length heavy chains may escape endoplasmic reticulum trapping and form signalling 
competent receptors (Geraldes et al., 2007). 
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Signalling by unpaired surface μ heavy chain may not be the only mechanism promoting 
mature B cell survival. Thus, we addressed if other mechanisms in addition to receptor-
generated signalling could be involved. Our results showing expression of unpaired μ heavy 
chain in the cytoplasm of light chain-negative B cells suggest the possibility that cytoplasmic 
μ heavy-chain also contributes to the survival of mature B cells through unfolded protein 
responses (UPR) (Geraldes et al., 2007). We found that heavy chain-only cells do generate 
long lived B cells, and differentiate into heavy chain producing cells(Geraldes et al., 2007). 
 
Our results showing long-term survival of B cells expressing HC unpaired with LC support the 
concept that a B cell autonomous mechanism independent of BCR and BCR specificity 
governs B cell longevity. Since our publication, research by Zhou et al. (Zhou et al., 2013) 
confirmed our conclusion that B cells expressing unpaired immunoglobulin heavy chain 
survive. These authors showed that termination of light chain expression by inducible deletion 
of an Igκ enhancer not only is compatible with B cell survival but promotes recombination 
activation gene expression and rearrangement of the lambda light chain locus. Since loss of 
light chain is often a consequence of Ig somatic hypermutation, signalling by unpaired 
immunoglobulin heavy chain might be essential to the development of tolerance by receptor 
editing. 
 
The findings related in this thesis identifying the contribution of unpaired immunoglobulin 
heavy chain to enhance the survival of mature B cells is of relevance for the development of B 
cell neoplasms. Although B cell neoplasms that express only immunoglobulin heavy-chains 
are rare (heavy chain-disease) (Fermand and Brouet, 1999) the contribution of unpaired heavy 
chains to malignancy may extend to B cell lymphomas in which there is an imbalance between 
Ig heavy chain and light chain expression. Recent work by Jardin et al. (Jardin et al., 2013) 
identified excess of μ-heavy chain as an independent risk factor for poor prognosis and 
response to therapy in diffuse large B cell lymphoma, which is the most common type of non-
Hodgkin lymphoma.  
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Activation of B cells is accompanied by profound chromatin changes that include multiple 
DNA double strand breaks. DNA breaks often cause cells to die and yet B cells not only 
survive but those that do so acquire long lives in the process. Indeed, most of the cells that 
contribute to memory responses which can live several decades, have undergone somatic 
hypermutation and immunoglobulin class switch recombination which cannot be completed 
without DNA breaks and recombination. To address the question of how B cells survive DNA 
double strand breaks during terminal differentiation, we examined the role of activation-
induced cytidine deaminase (AID), the enzyme that initiates somatic hypermutation (SHM) 
and class switch recombination (CSR) of Ig genes in DNA repair thus rescuing B cells from 
DNA damage induced apoptosis. Our studies demonstrated that AID recruits DNA PKcs 
suggesting that AID effectively coordinates repair in addition to promoting DNA breaks.  
Consistent with this notion, compromised class switch recombination is a common phenotype 
in mice deficient in proteins that are necessary for DNA damage repair(Matthews et al., 2014; 
Zahn et al., 2014).   
 
We proposed a working model to explain how AID promotes survival of cells undergoing 
DNA double strand breaks. AID binding to DNA through the DNA deamination domain 
undergoes a conformational change resulting in the exposure of the C-terminal domain that, in 
turn, recruits DNA-Protein kinase, catalytic sub-unit (PKcs) to the DNA. Upon the generation 
of DNA breaks by cytidine deamination, DNA-PKcs initiates non-homologous end joining by 
dissociating from AID and re-associating with Ku80 to assemble the non-homologous end 
joining repair complex. Our results suggest that the mechanism underlying hyper IgM type II 
syndrome associated with AID mutations that truncate the C-terminal portion of the molecule 
are owed to selective death of B cells stimulated to undergo class switch recombination 
because of accumulation of DNA double strand breaks. That C-terminal deleted AID mutants 
may sustain somatic hypermutation (Ta et al., 2003) is also in agreement with our findings 
since somatic hypermutation is less dependent on the recruitment of DNA-PKcs than class 
switch recombination, possibly due to engagement of alternative repair mechanisms (Bardwell 
et al., 2004; Cascalho et al., 1998). Our results may also explain why lack of DNA-PKcs 
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causes class switch deficiency for all isotypes except IgG1 (Manis et al., 2002), while the 
Severe combined immune-deficiency mutation, which truncates DNA-PKcs, allows moderate 
class switching to all isotypes (Bosma et al., 2002). While AID in the absence of DNA-PKcs 
is unable to recruit repair factors to the sites of cytidine deamination, it may do so in the 
presence of DNA-PKcs with the SCID mutation. The role of DNA-PK in determining the fate 
of AID induced lesions has been subject of a recent publications. Zahn et al. (Zahn et al., 
2014) showed that deletions in the AID C-terminal preclude the DNA repair response 
necessary to resolve the AID induced DNA lesions and promote Ig class switch 
recombination, in part by interacting with Ku70, a DNA-PK co-factor. These results confirm 
our finding showing that DNAPK and Ku70/Ku80 heterodimers are recruited by AID to 
promote non-homologous end-joining and class switch recombination (Wu et al., 2005). Singh 
et al. (Singh et al., 2013) extended these concepts by showing that exclusion of DNA-PK, by 
interaction with RNA export factor germinal centre associated nuclear protein, from AID-
induced lesions, steers resolution of DNA breaks towards homologous recombination and 
gene conversion in chicken-derived DT40 cells. 
 
Our research revealed for the first time a mechanism linking introduction of mutations and B 
cell survival. Other mechanisms have been suggested and are the subject of a recent review by 
(Matthews et al., 2014). Chen et al. (Chen et al., 2014, 2015) found that germinal center B 
cells were much less likely to develop genomic instability than B cells activated in vitro by 
cytokines in spite of similar targeting by AID. The research suggests that the B cell 
environment defines susceptibility to genomic lesions caused by Ig diversification. 
 
In summary, my thesis work revealed for the first time that unpaired heavy chain promotes B 
cell survival on its own, contributing a mechanism that may be of import in the establishment 
of tolerance or its failure and contributing to neoplastic transformation of B cells. The second 
manuscript introduced the new concept that the success of the Ig mutator (AID) to generate Ig 
diversification depends on its intrinsic ability to recruit certain DNA repair pathways to the 
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lesions created assuring diversification rather than repair with return to the germline 
configuration.  
  
 149 
References 
 
 
Bardwell, P.D., Woo, C.J., Wei, K., Li, Z., Martin, A., Sack, S.Z., Parris, T., Edelmann, W., 
and Scharff, M.D. (2004). Altered somatic hypermutation and reduced class-switch 
recombination in exonuclease 1-mutant mice. Nature immunology 5, 224-229. 
Bosma, G.C., Kim, J., Urich, T., Fath, D.M., Cotticelli, M.G., Ruetsch, N.R., Radic, M.Z., and 
Bosma, M.J. (2002). DNA-dependent protein kinase activity is not required for 
immunoglobulin class switching. The Journal of experimental medicine 196, 1483-1495. 
Cascalho, M., Wong, J., Steinberg, C., and Wabl, M. (1998). Mismatch repair co-opted by 
hypermutation. Science 279, 1207-1210. 
Chen, Z., Ranganath, S., Viboolsittiseri, S.S., Eder, M.D., Chen, X., Elos, M.T., Yuan, S., 
Hansen, E., and Wang, J.H. (2014). AID-initiated DNA lesions are differentially processed in 
distinct B cell populations. Journal of immunology 193, 5545-5556. 
Chen, Z., Ranganath, S., Viboolsittiseri, S.S., Eder, M.D., Chen, X., Elos, M.T., Yuan, S., 
Hansen, E., and Wang, J.H. (2015). Correction: AID-Initiated DNA Lesions Are Differentially 
Processed in Distinct B Cell Populations. Journal of immunology 194, 1383. 
Fermand, J.P., and Brouet, J.C. (1999). Heavy-chain diseases. Hematol Oncol Clin North Am 
13, 1281-1294. 
Geraldes, P., Rebrovich, M., Herrmann, K., Wong, J., Jack, H.-M., Wabl, M., and Cascalho, 
M. (2007). Ig heavy chain promotes mature B cell survival in the absense of light chain. 
Journal of immunology 179, 1659-1668. 
Jardin, F., Delfau-Larue, M.H., Molina, T.J., Copie-Bergman, C., Briere, J., Petrella, T., 
Canioni, D., Fabiani, B., Jais, J.P., Figeac, M., et al. (2013). Immunoglobulin heavy 
chain/light chain pair measurement is associated with survival in diffuse large B-cell 
lymphoma. Leukemia & lymphoma 54, 1898-1907. 
 150 
Manis, J.P., Dudley, D., Kaylor, L., and Alt, F.W. (2002). IgH class switch recombination to 
IgG1 in DNA-PKcs-deficient B cells. Immunity 16, 607-617. 
Matthews, A.J., Zheng, S., DiMenna, L.J., and Chaudhuri, J. (2014). Regulation of 
immunoglobulin class-switch recombination: choreography of noncoding transcription, 
targeted DNA deamination, and long-range DNA repair. Advances in immunology 122, 1-57. 
Singh, S.K., Maeda, K., Eid, M.M., Almofty, S.A., Ono, M., Pham, P., Goodman, M.F., and 
Sakaguchi, N. (2013). GANP regulates recruitment of AID to immunoglobulin variable 
regions by modulating transcription and nucleosome occupancy. Nature communications 4, 
1830. 
Ta, V.T., Nagaoka, H., Catalan, N., Durandy, A., Fischer, A., Imai, K., Nonoyama, S., 
Tashiro, J., Ikegawa, M., Ito, S., et al. (2003). AID mutant analysis indicate requirement for 
class-switch-specific cofactors. Nature immunology 4, 843-847. 
Wu, X., Geraldes, P., Platt, J.L., and Cascalho, M. (2005). The double-edged sword of 
activation-induced cytidine deaminase. Journal of immunology 174, 934-941. 
Zahn, A., Eranki, A.K., Patenaude, A.M., Methot, S.P., Fifield, H., Cortizas, E.M., Foster, P., 
Imai, K., Durandy, A., Larijani, M., et al. (2014). Activation induced deaminase C-terminal 
domain links DNA breaks to end protection and repair during class switch recombination. 
Proceedings of the National Academy of Sciences of the United States of America 111, E988-
997. 
Zhou, X., Xiang, Y., Ding, X., and Garrard, W.T. (2013). Loss of an Igkappa gene enhancer in 
mature B cells results in rapid gene silencing and partial reversible dedifferentiation. 
Molecular and cellular biology 33, 2091-2101. 
 
 
